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APD: action potential duration 
AN: autonomic neuropathy 
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BMI: body mass index 
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1. Introduction 
 
Myocardial hypertrophy has been shown to cause electrophysiological remodeling where the 
expression of different ion channels is altered. Myocardial hypertrophy in pathological 
settings in humans [Janse 2004; Li et al. 2004; Nattel et al. 2007] and in animal models, 
especially in the chronic atrioventricular (AV) block dog model [Vos et al. 1998] and heart 
failure models [Nuss et al. 1999; Li et al. 2002; Rose et al. 2005], has been shown to cause 
electrophysiological remodeling where the expression of different ion channels, including 
potassium channels critical for repolarization (i.e. IKs, IKr and IK1), is downregulated. These 
changes have been associated with increased incidence of serious ventricular arrhythmias 
probably due to decreased repolarization reserve [Vos et al. 1998; Nuss et al. 1999; Volders et 
al. 1999; Li et al. 2002; Rose et al. 2005;]. It is conceivable that prolonged repolarization and 
a possibly impaired repolarization reserve might represent increased risk for the development 
of ventricular arrhythmias, including Torsades de Pointes ventricular tachycardia (TdP) that 
can degenerate into ventricular fibrillation and lead to sudden cardiac death [Biliczki et al. 
2002; Lengyel et al. 2004]. 
 The identification of patients at risk for serious ventricular arrhythmia and sudden 
cardiac death is critically important. Current techniques for the reliable prediction of TdP and 
other, potentially fatal ventricular arrhythmias remain unsatisfactory. Electrocardiographic 
(ECG) parameters have been studied for their utility as prognostic non-invasive markers in 
sudden cardiac death (SCD) risk assessment. The prolongation of the frequency corrected QT 
interval (QTc) and increased QTc dispersion (characterizing spatial repolarization 
heterogeneity) were observed in patients with hypertrophic cardiomyopathy (HCM) [Buja et 
al. 1993; Dritsas et al. 1992; Yi et al. 1998]. However, QTc prolongation and QTc dispersion 
have been found not to be predictive for SCD in HCM patients [Yi et al. 1998; Maron et al. 
2001]. Moreover, QT interval prolongation alone cannot reliably predict the development of 
ventricular arrhythmias including the chaotic ventricular tachycardia, Torsades de Pointes 
(TdP), since cardiac repolarization reserve may be reduced even without significant changes 
in the duration of cardiac repolarization [Varró et al. 2011]. 
 The Tpeak-Tend interval, another ECG parameter representing spatial (including 
transmural) dispersion of repolarization [Antzelevitch 2001], has been shown to more reliably 
predict the development of Torsades de Pointes (TdP) polymorphic ventricular tachycardia in 
congenital [Schwartz et al. 2001] and acquired long QT syndromes than QTc prolongation or 
increased QT dispersion [Yamaguchi et al. 2003].  
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 Based on recent evidence, in addition to the prolonged QTc or Tpeak-Tend intervals, 
the short-term variability of the duration of repolarization (STVQT) [Berger et al. 1997] might 
be a better parameter to predict serious ventricular arrhythmias and sudden cardiac death, as it 
has been suggested by both animal experimental work [Thomsen et al. 2004; Thomsen et al. 
2005; Lengyel et al. 2007; Hanton et al. 2008] and recent clinical studies [Hinterseer et al. 
2008; Hinterseer et al. 2009; Hinterseer et al. 2010; Oosterhof et al. 2011]. On the basis of 
these observations, Varkevisser et al. [Varkevisser et al. 2012] suggested that beat-to-beat 
STVQT could be superior to QT interval prolongation in identifying patient populations at risk 
for ventricular arrhythmias and might be able to accurately predict individual risk. 
 
Physical conditioning in competitive athletes induces cardiovascular adaptation 
including lower resting heart rate (increased vagal tone) and increased cardiac mass 
(hypertrophy) and volume as a consequence of increased demand on the cardiovascular 
system, called „athlete’s heart” [Atchley et al. 2007]. Echocardiography studies show that 
myocardial hypertrophy develops following long-term sports activities [Scharhag et al. 2002; 
Atchley et al. 2007; Paolo et al. 2007]. Sudden death among young athletes is rare (1:50 000–
1:100 000), however, it is still 2–4 times more frequent than in age-matched controls [Corrado 
et al. 2007]. Numerous congenital and acquired cardiac diseases have been identified as 
causes of SCD in athletes [Pigozzi and Rizzo 2008]; however, in 5-10 % of SCD cases no 
structural abnormalities are detected in the heart during autopsy [Maron et al. 1980; Maron et 
al. 1996], the exact mechanism of SCD in these cases is not established and is mostly 
attributed to ventricular fibrillation.  
 
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disease with a 
prevalence of one in 500 in the general population [Maron et al. 1995], characterized by 
marked but variable left ventricular hypertrophy and myocardial fibrosis [Gersh et al. 2011]. 
HCM is associated with lethal ventricular arrhythmias [Wigle et al. 1995; Maron 2002; Gersh 
et al. 2011], and it is the most common cause of SCD in young individuals [Decker et al. 
2009; Maron 2010] and in competitive athletes younger than 35 years [Maron et al. 2009].  
The reliable assessment of SCD risk in individual HCM patients and the identification 
of patients for implantable cardioverter defibrillator (ICD) implantation, the most effective 
intervention for SCD prevention, are critically important. Currently models for SCD risk 
stratification uses non-invasive conventional clinical markers and all of them exhibit a low 
positive predictive value and the current SCD risk assessment algorithm in HCM is still 
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considered incomplete and hampered by lack of sufficient evidence for all elements 
[McKeown and Muir 2013]. This notion is supported by SCD events in HCM patients who 
were not considered to be at high risk for SCD [Maron et al. 2008]. 
 
Acromegaly, caused by pituitary tumors, is well-known to be associated with 
cardiovascular complications, such as hypertension, left ventricular hypertrophy, asymmetric 
septal hypertrophy, cardiomyopathy, and congestive heart failure [Melmed 2006]. Excessive 
secretion of growth hormone and insulin-like growth factor 1 (IGF-1) can result in major 
structural and functional changes in cardiac system and arrhythmias [Melmed 2006], and a 
specific cardiomyopathy develops in acromegaly associated with life-threatening 
dysrhythmias [Clayton 2003]. Moreover, acromegaly can also be associated with 
cardiovascular diseases contributing to increased mortality among patients [Clayton 2003; 
Melmed 2006]. Dysrhythmias, atrioventricular conduction delay and sick sinus syndrome 
were reported in sudden death in acromegalic heart disease. 
 
2. Aims 
The aims of this study were: 
2.1. to compare conventional ECG parameters as well as the short-term beat-to-beat temporal 
variability of the RR and QT intervals of professional soccer players to age-matched controls 
who do not participate in competitive sports; 
2.2. to compare conventional ECG parameters of repolarization and STVQT in HCM patients 
and age-matched healthy volunteers; 
2.3. to determine beat-to-beat QT variability in patients with acromegaly. 
 
3. Methods 
3.1. Patient population (general considerations)  
The study population consisted of male professional soccer players from the Hungarian 
Premier League, patients with hypertrophic cardiomyopathy (HCM) and patients with 
acromegaly. Age- and sex-matched healthy volunteers, who did not participate in sports 
activities, were eligible for this study as control subjects. Professional soccer players, patients, 
or age-matched controls were excluded if they had excessive (>5%) ectopic atrial or 
ventricular beats, were in a rhythm other than normal sinus, had repolarization abnormalities 
(i.e. early repolarization pattern, T wave inversion and complete left bundle branch block or 
right bundle branch block), had a permanent pacemaker or any other disorders such as serious 
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retinopathy, symptomatic cardiac and/or pulmonary disease, acute metabolic disease, had 
excessive noise on the electrocardiographic signal that precluded analysis of the ECG 
waveform, were on any medication likely to affect the investigated ECG parameters or 
consumed significant amount of food within 3 hours or drank alcohol, coffee or smoked 
within 10 hours. All of the control individuals, soccer players and patients were of European 
descent.  
 
3.2. Ethics Statement 
The studies described here were carried out in accordance with the Declaration of Helsinki 
(2000) of the World Medical Association and were approved by the Scientific and Research 
Ethical Committee of the Medical Scientific Board at the Hungarian Ministry of Health (ETT-
TUKEB), under ethical approval No. 4987-0/2010-1018EKU (338/PI/010). All subjects have 
given written informed consent of the study. 
 
3.3. Electrocardiography  
Five-minute 12-lead electrocardiograms were recorded from patients with HCM or 
acromegaly and age-matched healthy human volunteers at rest, in the supine position to 
obtain signals with the least amount of motion artefact. In athletes, baseline ECG recordings 
were taken before a competitive soccer game (Hungarian Premier League) and also 
approximately 20 minutes after the end of the game in the dressing room. In all leads the ECG 
signals were digitized at 2000 Hz sampling rate with a multichannel data acquisition system 
(Cardiosys A01 software, Experimetria Ltd., Budapest, Hungary; MDE Heidelberg GMBH, 
Heidelberg, Germany) connected to a personal computer and stored for later off-line analysis. 
The RR, QT intervals and duration of the T wave from the peak to the end (Tpeak-
Tend) intervals were measured using automated algorithms as the average of consecutive 30 
beats (minimum number of intervals needed for variability measurements), were checked by 
the investigator and manually corrected if needed and were calculated as the average of 30 
beats. Out of the repolarization parameters we analyzed the QT dispersion (QTd), the 
frequency corrected QT intervals (QTc) performed by the Bazett’s (QTc = QT / √RR), 
Fridericia (QTc = QT / [RR/1000]1/3), Framingham (QTc = QT + [0.154 * {1000-RR}]) and 
the Hodges formulas (QTc = QT + 1.75 * [60 000 / RR-60]). The QTc interval duration was 
defined as the mean duration of all QTc intervals measured. As no statistical difference was 
noted between different correction methods with regard to corrected QT interval, QTc 
corrected with the Bazett’s formula was used for further comparisons. The PQ and QRS 
 5 
intervals were measured as the average of 15 consecutive beats. All measurements were 
carried out using lead II and in case of excessive noise lead II, lead V5.  
The calculation of the short-term beat-to-beat variability of repolarization was chosen 
since it is a relatively simple method that has been suggested as a future screening tool; 
moreover it has been shown in animal studies [Thomsen et al. 2004; Lengyel et al. 2007] and 
in certain patient populations [Hinterseer et al. 2009; Hinterseer et al. 2010] to reliably predict 
increased arrhythmia propensity. 
Using 30 consecutive beats, RR and QT intervals were plotted against their respective 
previous interval and Poincaré plots were constructed as described previously [Volders et al. 
1999]. The instability of beat-to-beat heart rate and repolarization were characterized by the 
short-term variability (STV) of the RR and QT intervals, and were calculated using the 
following formula: STV =∑|Dn+1-Dn| / (30 * √2), where D is the duration of the RR or QT 
intervals. This calculation defines the STV as the mean distance of points perpendicular to the 
line of identity in the Poincaré plot and relies on previous mathematical analysis [Brennan et 
al. 2001]. 
 
3.4. Echocardiography 
3.4.1. Professional soccer players 
Echocardiographic measurements were performed at rest on 23 professional soccer players 
and 23 age-matched controls using a Dornier AI 4800 (Germany) echocardiograph with a 2.5 
MHz transducer. Two-dimensionally guided M-mode recordings were obtained parasternally 
in accordance with the recommendations of the American Society of Echocardiography [Sahn 
et al. 1978]. Measurements were carried out as described previously [Pavlik et al. 1996]. For 
purely logistic reasons, not all control individuals and soccer players were subjected to 
echocardiography. 
 
3.4.2. Patients with HCM and acromegalic patients 
All HCM and acromegalic patients and all controls underwent transthoracic 
echocardiographic examination performed by the single observer blinded to subject data for 
all participants. Two-dimensional echocardiographic images were obtained by a commercially 
available Toshiba Powervision 8000 echocardiography equipment, in a number of cross-
sectional planes using standard imaging positions to determine standard morphological and 
functional parameters [left ventricular end-systolic diameter (LVESD), left ventricular end-
diastolic diameter (LVEDD), ejection fraction (EF), left atrial diameter (LA), resting left 
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ventricular outflow tract (LVOT) peak gradient]. Maximal left ventricular wall thickness 
(LVmax) was defined as the largest wall thickness of the left ventricle at any left ventricular 
segment. LVmax was also normalized for body surface area (LVmax BSA).  
 
3.5. Cardiac MRI in HCM patients 
In all HCM patients, cardiac magnetic resonance imaging (MRI) was carried out to determine 
the left ventricular mass (LVM). MRI assessments were performed in supine position with the 
head first on a commercially available 1.5T scanner (Signa Excite HDxT, GE Medical 
Systems) using a phased-array body coil. Sequential gradient-echo short-axis cine images 
(base to apex; slice thickness: 8 mm; field of view: 43 mm; matrix: 224 * 224; repetition time: 
100 milliseconds) covering the entire left ventricule (LV) were acquired during breath hold 
after normal expiration. Three long-axis images (2-, 3- and 4-chamber views) were also 
acquired. The acquisition was triggered by ECG. The gradient-echo short-axis images were 
used to measure LVM by planimetry of the manually defined endocardial and epicardial 
borders on each short-axis image covering the entire LV. The measurement was performed in 
both end diastole and end systole to enable calculation of LV ejection fraction. Papillary 
muscles were not included in the LVM. LVM was also normalized for body surface area 
(LVM BSA). 
 
3.6. Autonomic function and laboratory assessment in patients with acromegaly 
Autonomic function was assessed by means of five standard cardiovascular reflex tests: the 
heart rate (HR) responses to deep breathing and to standing up (30/15 ratio), the Valsalva 
maneuver, the systolic blood pressure response to standing up, and the diastolic pressure 
change during a sustained handgrip. A score was created to express the severity of autonomic 
neuropathy (AN), based on the results of the five tests (normal: 0, borderline: 1, abnormal: 2). 
The total score was in the interval of 0 to 10. 
Fasting venous blood samples were obtained from each patient and controls for the 
determination of serum glucose, blood urea nitrogen, creatinine, sodium and potassium levels. 
Human growth hormone (hGH) and IGF-1 were measured by chemiluminescent 
immunoassay (IMMULITE 1000 Immunoassay System, Siemens. hGH measurement 
comparator: Recombinant 98/574; detection limit: 0.01 ng/ml; intra-assay coefficients of 
variation: 6.0 %; interassay coefficients of variation: 6.2 %. IGF-1 measurement comparator: 
WHO IRP 87/517; detection limit: 20.0 ng/ml; intra-assay coefficients of variation: 5.0 %; 
interassay coefficients of variation: 9.0 %). 
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3.7. Statistics 
3.7.1. Professional soccer players 
Body weight, body mass index (BMI), age and ECG interval data are expressed as means ± 
standard error of the mean (SEM). Comparisons between controls and soccer players were 
made using the unpaired Student’s t-test. ECG parameters of athletes before and after the 
game were compared by one-way analysis of variance (ANOVA) followed by a paired t-test. 
A p value of < 0.05 was considered significantly different. Statistical analyses were 
performed using Statistica for Windows (version 9). 
 
3.7.2. Patients with HCM 
All data are expressed as mean ± standard deviation (SD). Comparisons between HCM 
patients and controls for the study variables were done using the independent samples 
Student’s t-test for normally distributed parameters. Normal distribution was verified by the 
Kolmogorov-Smirnov test. Degree of association between two variables was expressed by the 
Pearson correlation coefficient (r). The statistical analyses were performed using the MedCalc 
software package (ver. 14.12.0). Statistical significance was accepted at the p < 0.05 level. 
 
3.7.3. Acromegalic patients 
All data are expressed as mean ± SD. Comparisons between acromegalic patients and controls 
for the study variables were done using the unpaired Student’s t-test for normally distributed 
parameters, nonparametric Mann-Whitney U test for non-normal distributions, and linear 
regression for revealing correlations. The statistical analyses were performed using the SPSS 
16.0 software package. Statistical significance was accepted at the p < 0.05 level.  
 
4. Results 
4.1. Short-term variability of the QT interval in professional soccer players 
4.1.1. Study population 
The study population consisted of 76 male professional soccer players from the Hungarian 
Premier League (age 16 to 39, mean 22.0 ± 0.61 years; weight 76.2 ± 0.95 kg, BMI 23.2 ± 
0.18 kg/m2), and 76 male, age-matched healthy control sedentary subjects who did not 
participate in sports activities (age 15 to 39, mean 22.0 ± 0.54 years; weight 77 ± 1.7 kg, BMI 
23.3 ± 0.48 kg/m2). 
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4.1.2. Echocardiographic measurements in study subjects 
Professional soccer players exhibited significantly higher values in interventricular septum, 
left ventricular posterior wall thickness and in left ventricular end-diastolic diameter 
compared to age-matched controls (Table 1). These results were not unexpected and were 
supportive of the presence of athlete’s heart in these professional soccer players. 
 
Table 1. Echocardiographic parameters in professional soccer players and age-matched 
controls 
   Controls Soccer players 
IVS (mm) 9.0 ± 0.31 10.2 ± 0.20** 
PW (mm) 9.1 ± 0.9 9.9 ± 0.14** 
LVEDD (mm) 48.1 ± 0.95 50.6 ± 0.80* 
LVESD (mm) 31.9 ± 0.96 33.3 ± 0.66 
Values are presented as mean ± SEM. 
Abbreviations: IVS: interventricular septum thickness; PW: posterior wall thickness; 
LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic 
diameter.  
*p < 0.05, **p < 0.01 vs control. n = 23 in each group. 
 
4.1.3. Heart rate, QT and QTc intervals in study subjects  
The development of athlete’s heart in response to long-term physical conditioning is 
characterized by increased vagal tone. As expected, the RR intervals in soccer players were 
significantly longer before the game compared to age-matched volunteers (Table 2 and Figure 
1A). Consequently, the heart rate of professional soccer players was lower compared to the 
control group before the game (Figure 1B). However, after the soccer game the heart rates of 
athletes were higher than in controls (Figure 1B). The duration of cardiac repolarization is 
cycle length dependent where slower heart rates lead to prolonged repolarization. 
Accordingly, significantly longer QT intervals were measured in soccer players before the 
game (Table 2 and Figure 2). However, after the game these differences in QT intervals were 
not observed, since heart rates of athletes were close to controls, while the QT intervals in 
soccer players were significantly shorter than before the game (Table 2 and Figure 2). 
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Table 2. Heart rate, QT and QTc intervals in professional soccer players and age-
matched controls 
   Control Soccer players before game 
Soccer players 
following game 
RR (ms) 861 ±  17 1017 ± 19*** 765 ± 21*** ### 
QT (ms) 390 ± 4 419 ± 3*** 383 ± 3*** ### 
QTc (ms) Bazett 423 ± 3 418 ± 2 443 ± 3*** ### 
QTc (ms) Fridericia 411 ± 2 418 ± 2* 421 ± 2*** 
QTc (ms) Framingham 411 ± 2 417 ± 2 420 ± 2** 
QTc (ms) Hodges 411 ± 2 420 ± 2*** 422 ± 2*** 
Values are presented as mean ± SEM. 
Abbreviations: QTc: frequency corrected QT interval (calculated by the Bazett’s, Fridericia, 
Framingham and Hodges formulas). 
*p < 0.05; **p < 0.01; ***p < 0.001 vs age-matched control; ###p < 0.001 vs before game 
values.  n = 76 in each group. 
 
 
Figure 1. The RR interval (A) and heart rate (B) of age-matched controls and 
professional soccer players before and following a competitive game 
 
Values are presented as mean ± SEM. 
***p < 0.001 vs age-matched control; ###p < 0.001 vs before game values. n = 76 in each 
group. 
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Figure 2. The QT intervals of age-matched controls and professional soccer players 
before and following a competitive game 
 
Values are presented as mean ± SEM. 
***p < 0.001 vs age-matched control; ###p < 0.001 vs before game values. n = 76 in each 
group. 
 
 
In order to reliably assess the duration of ventricular repolarization and to minimize 
the influence of changing heart rate on the QT interval, it is necessary to carry out frequency 
correction of the QT interval. However, it has been shown that Bazett’s and Fridericia 
correction formulas described over 90 years ago [Bazett 1920; Fridericia 1920] overestimate 
changes in QT interval [Indik et al. 2006]. Therefore, in this study, to calculate the frequency 
corrected QT interval (QTc) we also used Framingham and Hodges correction formulas 
shown to alter the accuracy of QT interval changes due to heart rate in a smaller degree [Indik 
et al. 2006]. In this regard, QTc calculated using the Bazett’s and Framingham formulas were 
not different in athletes before the game compared to controls (Table 2; Figures 3A and D), 
while QTc values calculated with the other two formulas were significantly longer in players 
before the game (Table 2; Figures 3B and D). In addition, QTc was significantly prolonged in 
soccer players following the game compared to control values calculated with all correction 
formulas in the present study (Table 2 and Figures 3A–D). Only QTc calculated with the 
Bazett’s formula showed a large and significant prolongation in soccer players after the game 
compared to pre-game values (Table 2 and Figures 3A–D). 
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Figure 3. Frequency corrected QT interval of age-matched controls and professional 
soccer players before and following a competitive game 
 
Values are presented as mean ± SEM. 
Abbreviation: QTc: frequency corrected QT interval (calculated by the Bazett’s, Fridericia, 
Framingham and Hodges formulas). 
*p < 0.05; **p < 0.01; ***p < 0.001 vs age-matched control; ###p < 0.001 vs before game 
values. n = 76 in each group. 
 
 
4.1.4. Short-term beat-to-beat temporal variability of the RR and QT intervals  
To characterize the instability of cardiac ventricular repolarization, the short-term beat-to-beat 
variability of the QT interval was calculated in professional soccer players and age-matched 
controls. Since it is reasonable to assume that STVQT can be, at least in part, influenced by the 
short-term beat-to-beat temporal variability of the RR interval (STVRR), the STVRR was also 
calculated in both groups. Soccer players before the competitive game exhibited a 
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significantly larger STVRR compared to controls; however, this difference disappeared after 
the game, when their heart rates were close to controls (Table 3 and Figure 4A). As individual 
representative examples (Poincaré plots) and grouped average data show, the short-term beat-
to-beat variability of the QT interval was significantly higher in soccer players compared to 
controls (Table 3; Figures 4B and C). Importantly, and unlike the STVRR, the STVQT was still 
significantly higher in soccer players compared to controls but was also reduced after the 
game compared to pre-game values (Table 3; Figure 4C). 
 
Table 3. Short-term beat-to-beat temporal variability of the RR and QT intervals in 
professional soccer players and age-matched controls 
   Control Soccer players before game 
Soccer players 
following game 
STVRR (ms) 28.2 ±  2.2 44.9 ± 3.3*** 23.4 ± 4.1### 
STVQT (ms) 3.5 ± 0.1 4.8 ± 0.1*** 4.3 ± 0.1*** ## 
Values are presented as mean ± SEM. 
Abbreviations: STVRR: short-term beat-to-beat temporal variability of the RR interval; 
STVQT: short-term beat-to-beat temporal variability of the QT interval.  
***p < 0.001 vs age-matched control; ##p < 0.01; ###p < 0.001 vs before game values. n = 76 
in each group. 
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Figure 4. Short-term beat-to-beat temporal variability of the RR (STVRR) and QT 
(STVQT) intervals in age-matched controls and professional soccer players before and 
following a competitive game 
 
Values are presented as mean ± SEM. 
Abbreviations: STVRR: short-term beat-to-beat temporal variability of the RR interval; 
STVQT: short-term beat-to-beat temporal variability of the QT interval.  
***p < 0.001 vs age-matched control; ##p < 0.01; ###p < 0.001 vs before game values. n = 76 
in each group. 
 
 
Histograms on Figures 5 and 6 show the distribution of QT interval and STVQT values 
within the control and soccer player groups, respectively. The histograms clearly exhibit a 
shift to the right in the distribution of both QT intervals and STVQT in soccer players before 
the competitive game compared to controls (Figures 5A and 6A). However, while the 
distribution of QT intervals shows a similar pattern in soccer players to controls following the 
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game (Figure 5B); the distribution pattern of STVQT largely remained unchanged after the 
game (Figure 6B). These results suggest that the increased STVQT in soccer players is very 
unlikely caused by the prolonged QT interval itself in these athletes.  
 
Figure 5. Histograms showing the distribution of the QT interval 
 
(A) Controls (empty bars) and soccer players before game (full bars) and (B) controls (empty 
bars) and soccer players after the game (hashed bars). Bin size is 10 ms. n = 76 in each group. 
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Figure 6. Histograms showing the distribution of short-term beat-to-beat temporal 
variability of the QT interval (STVQT) 
 
(A) Controls (empty bars) and soccer players before game (full bars) and (B) controls (empty 
bars) and soccer players after the game (hashed bars). Bin size is 0.5 ms.  
Abbreviation: STVQT: short-term beat-to-beat temporal variability of the QT interval.  
n = 76 in each group. 
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In six players before the game the STVQT was markedly larger than the average STVQT 
in the soccer player group (9.7, 7.2, 7.0, 7.0, 6.7, 6.7 and group average was 4.8 ± 0.14 ms; 
Figure 6). Since increased STVQT has been associated with increased proarrhythmic risk in 
certain patient populations, the player who had 9.7 ms STVQT was contacted and the 
measurement was repeated to yield a heart rate of 47/min and an STVQT of 5.0 ms, however, 
before the repeated measurement he had been injured for 2 months. Whether this smaller (but 
still higher and close to the group average) STVQT on repeated measurement was due to the 
well-known de-training phenomenon in an athlete who had been out of training due to injury 
was unclear. 
 
 
4.2. Short-term variability of the QT interval and correlation with parameters of left  
       ventricular hypertrophy in patients with hypertrophic cardiomyopathy 
4.2.1. Study population 
Thirty-seven consecutive patients with hypertrophic cardiomyopathy (HCM) were enrolled 
into the study. The diagnosis of HCM was based on established diagnostic criteria [Gersh et 
al. 2011]. Among the 37 HCM patients, 24 patients were taking beta blockers and 8 patients 
were taking verapamil as first line therapy. Three patients were taking cardiac medications 
known to prolong QT interval (two were taking amiodarone and one was taking propafenone). 
None of the patients were on any other drug therapy with known QT interval prolonging 
effect. 
A total of 37 age- and gender-matched healthy volunteers (mean age 43 ± 12 years, 
males/females 21/16) without a history or evidence of heart disease was enrolled in the study 
as controls. Body mass index was significantly lower in the control group (25 ± 4 vs 28 ± 6 
kg/m2, p = 0.007, see Table 4). 
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Table 4. The main demographical, clinical and echocardiographic parameters of the 
patients with HCM and controls 
   Control HCM 
n 37 37 
Sex (male/female) 21/16 21/16 
Age (year) 43 ± 12 48 ± 15 
BMI (kg/m2) 25 ± 4 28 ± 6* 
BMI ≥30/≥25/<25 kg/m2 (n) 5/13/19 11/16/10 
NYHA class 0/1/2/3 (n) 19/18/0/0 0/5/26/6**** 
EF (%) 68 ± 6 69 ± 9 
LVEDD (mm) 48 ± 4 46 ± 7 
LVESD (mm) 30 ± 4 27 ± 7* 
IVS (mm) 9 ± 1 20 ± 6*** 
PW (mm) 9 ± 1 11 ± 2*** 
Values are represented as mean ± SD. 
Abbreviations: HCM: hypertrophic cardiomyopathy; BMI: body mass index; NYHA: New 
York Heart Association; EF: ejection fraction; LVEDD: left ventricular end-diastolic 
diameter; LVESD: left ventricular end-systolic diameter; IVS: interventricular septum 
thickness; PW: posterior wall thickness. 
*p < 0.05, ***p < 0.001, ****p < 0.0001 vs control. 
 
 
4.2.2. Electrocardiographic parameters in HCM patients and controls 
Comparison of ECG parameters between HCM patients and controls are presented in Table 5. 
Patients with HCM exhibited significantly increased RR, PQ and QRS intervals. QTc was 
significantly prolonged in HCM patients (Figure 7A), regardless of the method used for QTc 
correction (using Bazett’s, Fridericia, Framingham or the Hodges formulas). There was no 
difference between QTc intervals in the HCM group obtained by the different correction 
methods. The terminal part of the T wave, the Tpeak-Tend interval was also markedly longer 
in HCM patients (Figure 7B). QT dispersion (Figure 7C) and short-term QT variability was 
also markedly increased in patients with HCM (Figure 7D). The largest relative increase 
among the different parameters was seen with regard to short-term QT variability with a 
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relative increase of 41%. Differences between the HCM and control groups remained highly 
significant when we excluded patients taking QT prolonging drugs (amiodarone or 
propafenone, n = 3) from the comparisons. BMI or obesity status did not correlate with either 
of the repolarization parameters. 
 
Table 5. Electrocardiographic parameters in HCM patients and controls 
 
   Control HCM Relative difference (%) 
RR (ms) 867 ±  119 947 ± 140* 9.2 
PQ (ms) 152 ± 17 166 ± 30* 8.5 
QRS (ms) 96 ± 7 112 ± 17*** 15.6 
QT (ms) 401 ± 24 473 ± 66*** 18.0 
QTc (ms) Bazett 434 ± 23 488 ± 61*** 13.0 
QTc (ms) Fridericia 422 ± 20 483 ± 60*** 14.7 
QTc (ms) Framingham 423 ± 19 481 ± 60*** 14.5 
QTc (ms) Hodges 420 ± 18 482 ± 60*** 15.0 
QTd (ms) 34 ± 9 47 ± 17** 37.1 
Tpeak-Tend (ms) 91 ± 10 107 ± 27* 18.9 
STVQT (ms) 3.2 ± 1 4.5 ± 2** 40.6 
Values are represented as mean ± SD and relative difference between the two groups in %. 
Abbreviations: HCM: hypertrophic cardiomyopathy; QTc: frequency corrected QT interval 
(calculated by the Bazett’s, Fridericia, Framingham and Hodges formulas); QTd: QT 
dispersion; Tpeak-Tend: duration of the T wave from the peak to the end; STVQT: short-term 
beat-to-beat temporal variability of the QT interval. 
*p < 0.05, **p < 0.001, ***p < 0.0001 vs control. n = 37 in each group. 
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Figure 7. Box and whisker plots illustrating significant differences between patients with 
HCM and controls  
 
Values are represented as mean ± SD. 
A) the frequency corrected QT interval (QTc, calculated by the Bazett’s formula); B) the 
duration of the T wave from the peak to the end (Tpeak-Tend); C) QT dispersion (QTd); D) 
short-term beat-to-beat temporal variability of QT interval (STVQT). The central box 
represents the values from the lower to upper quartile (25 to 75 percentile). The middle line 
represents the median. The vertical line extends from the minimum to the maximum value, 
excluding outside (open squares) and far out values (filled dots) which are displayed as 
separate points. n = 37 in each group.  
 
 
4.2.3. Correlation of repolarization parameters in HCM patients  
Correlation between different repolarization parameters, QT dispersion and short-term QT 
variability are given in Table 6. The QTc prolongation correlated significantly with the 
prolongation of the Tpeak-Tend interval, but not the QRS width, indicating that the QTc 
prolongation was, at least in part, due to the prolongation of the terminal phase of the T wave. 
Short-term QT variability showed a relatively strong correlation with the QTc prolongation 
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and with, to a lesser extent, with the Tpeak-Tend interval. The QT dispersion did not correlate 
with any of the repolarization parameters. 
 
Table 6. Correlation of repolarization parameters in HCM patients     
 
 QRS Tpeak-Tend QTd STVQT 
QTc 0.284 0.527*** - 0.013 0.616*** 
Tpeak-Tend 0.299 − 0.018 0.378* 
QTd 0.253 − − - 0.228 
Values are represented as Pearson correlation coefficient.  
Abbreviations: HCM: hypertrophic cardiomyopathy; QTc: frequency corrected QT interval 
(calculated by the Bazett’s formula); QTd: QT dispersion; Tpeak-Tend: duration of the T 
wave from the peak to the end; STVQT: short-term beat-to-beat temporal variability of the QT 
interval. 
*p < 0.05, ***p < 0.001 vs control. n = 37 in each group. 
 
 
4.2.4. Correlation between repolarization parameters and echocardiographic 
parameters in HCM patients 
Correlation between ECG repolarization parameters and echocardiography parameters in 
HCM patients showed no correlation between these parameters except for a weak correlation 
between short-term QT variability and left ventricular end-systolic diameter or left ventricular 
ejection fraction (data not shown). 
 
4.2.5. Correlation between repolarization parameters and indices of left ventricular 
hypertrophy determined by cardiac MRI technique in HCM patients  
Correlation between repolarization parameters and indices of left ventricular hypertrophy 
(maximal left ventricular wall thickness and left ventricular mass, measured by cardiac 
magnetic resonance imaging) with or without normalization for body surface area are shown 
in Table 7. Degree of correlation increased with normalization in almost all comparisons. 
Short-term QT variability showed significant, albeit modest correlation, with both un-
normalized and normalized indices of left ventricular hypertrophy (LVmax; LVmax BSA and 
LVM BSA, Figures 8 and 9). Tpeak-Tend interval also correlated significantly with some of 
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the hypertrophy parameters, but showed no significant correlation to the most reliable 
hypertrophy parameter, i. e. LVM indexed for BSA. 
 
Table 7. Correlation between repolarization parameters and morphologic parameters of 
hypertrophy in HCM patients 
 
 QTc Tpeak-Tend QTd STVQT 
IVS (mm) 0.099 0.344* - 0.144 0.285 
LVmax (mm) 0.216 0.450** - 0.238 0.381* 
LVmax BSA (mm/m2) 0.360* 0.451** - 0.129 0.461** 
LVM (g) 0.037 0.241 - 0.128 0.273 
LVM BSA (g/m2) 0.195 0.348 - 0.116 0.455* 
Values are represented as Pearson correlation coefficient.  
Abbreviations: HCM: hypertrophic cardiomyopathy; QTc: frequency corrected QT interval 
(calculated by the Bazett’s formula); Tpeak-Tend: duration of the T wave from the peak to the 
end; QTd: QT dispersion; STVQT: short-term beat-to-beat temporal variability of the QT 
interval; IVS: interventricular septum thickness; LVmax: maximal left ventricular wall 
thickness; LVmax BSA: maximal left ventricular wall thickness normalized for body surface 
area; LVM: left ventricular mass; LVM BSA: left ventricular mass normalized for body 
surface area. 
*p < 0.05, **p < 0.01 vs control. n = 37 in each group. 
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Figure 8. Scatter plot illustrating the correlation between short-term variability of QT 
interval and morphologic parameters of hypertrophy in HCM patients     
 
Values are represented as Pearson correlation coefficient (r).  
Correlation between maximal left ventricular wall thickness normalized for body surface area 
(LVmax BSA) and A) the frequency corrected QT interval (QTc, calculated by the Bazett’s 
formula); B) the duration of the T wave from the peak to the end (Tpeak-Tend); C) QT 
dispersion (QTd); D) short-term beat-to-beat temporal variability of QT interval (STVQT). 
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Figure 9. Scatter plot illustrating the correlation between left ventricular mass 
normalized for body surface area and repolarization parameters   
 
Values are represented as Pearson correlation coefficient (r).  
Scatter plot illustrating the correlation between left ventricular mass normalized for body 
surface area (LVM BSA) and A) the frequency corrected QT interval (QTc; calculated by the 
Bazett’s formula); B) the duration of the T wave from the peak to the end (Tpeak-Tend); C) 
QT dispersion (QTd); D) short-term beat-to-beat temporal variability of QT interval (STVQT). 
 
4.3. Short-term variability of QT interval in patients with acromegaly 
4.3.1. Clinical data of acromegalic patients and control subjects  
In 30 acromegalic patients studied, body weight and mean body mass index (BMI) were 
significantly higher (p < 0.001 for both parameters) than those in age- and sex-matched 
volunteers (Table 8). Mean systolic blood pressure did not differ significantly between control 
subjects and acromegalic patients receiving standard care and treatment, however, 
acromegalic patients had higher diastolic blood pressure (p < 0.05). The incidence of high 
blood pressure was 7/30 in control and 13/30 in acromegaly groups during the actual 
measurements. Average serum glucose and glycosylated hemoglobin (HbA1c) values were 
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also similar in both groups; incidences of diabetes were 0/30 and 1/30 in control and 
acromegaly groups, respectively. Incidence of impaired glucose tolerance was 0/30 in control 
and 4/30 in acromegalic subjects. Significant differences were seen in serum hGH (p = 
0.0028) and IGF-1 (p = 0.0013) levels between acromegalic and control groups. There was no 
significant difference in nadir value of hGH during oral glucose tolerance test (OGTT) 
between active (3.40 ± 2.10 ng/ml, n = 17) and inactive (1.80 ± 1.86 ng/ml, n = 13) 
acromegalic subgroups. However, significantly higher average hGH (7.00 ± 6.73 ng/ml vs 
2.03 ± 2.86 ng/ml, p = 0.0180) and IGF-1 (501.3 ± 359.6 ng/ml vs 198.5 ± 79.1 ng/ml, p = 
0.0060) concentrations were measured in active acromegalic subgroup compared to inactive 
one. 
 
Table 8. Clinical data of acromegalic patients and age-matched control subjects 
 Control Acromegaly 
Age (years) 51.3 ± 7.6 55.7 ± 10.4 
Weight (kg) 68.9 ± 14.7 87.7 ± 19.3** 
Height (cm) 165.1 ± 10.5 168.9 ± 8.2 
BMI (kg/m2) 25.1 ± 3.7 30.6 ± 5.3** 
Systolic BP (mmHg) 126.9 ± 13.4 133.2 ± 17.7 
Diastolic BP (mmHg) 75.5 ± 8.5 82.7 ± 12.4* 
0 min glucose (mmol/l) 5.04 ± 0.52 5.40 ± 0.71 
120 min glucose (mmol/l) 5.30 ± 1.30 6.30 ± 2.53 
HbA1c (%) 5.70 ± 0.50 5.90 ± 0.74 
hGH nadir following OGTT (ng/ml) 1.02 ± 1.42 2.72 ± 2.13* 
IGF-1 (ng/ml) 151.0 ± 51.4 370.1 ± 311.8* 
IGF-1 x ULN 0.50 ± 0.33 x ULN 1.66 ± 1.59 x ULN** 
Values are represented as mean ± SD.  
Abbreviations: BMI: body mass index; BP: blood pressure; HbA1c: glycosylated 
hemoglobin; hGH: human growth hormone; OGTT: oral glucose tolerance test; IGF-1: 
insulin-like growth factor-1; ULN: upper limit of normal value.  
*p < 0.05, **p < 0.001 vs control. n = 30 in each group.  
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4.3.2. Echocardiographic measurements in study subjects 
There were significant differences between the two groups in the echocardiographic 
dimensions. Patients with acromegaly exhibited significantly higher values in left ventricular 
end-diastolic and end-systolic diameter and in interventricular septum thickness, left 
ventricular posterior wall thickness compared to age-matched controls (Table 9). These 
results were not unexpected and were supportive of the presence of myocardial hypertrophy 
in the acromegalic patients and could be related to the duration and activity of the disease. 
However, no significant difference was detected in the echocardiographic parameters 
measured between active and inactive acromegaly subgroups (EF: 66.7 ± 7.4% vs 67.9 ± 
6.4%, LVEDD: 52.6 ± 4.9 mm vs 52.7 ± 6.1 mm, LVESD: 32.1 ± 5.9 mm vs 32.5 ± 4.3 mm, 
IVS: 10.6 ± 1.3 mm vs 11.8 ± 3.0 mm, PW: 10.5 ± 1.3 mm vs 11.2 ± 1.6 mm, respectively). 
 
Table 9. Echocardiographic parameters in patients with acromegaly and age-matched 
controls 
   Control Acromegaly 
EF (%) 70.6 ± 5.4 67.2 ± 6.9* 
LVEDD (mm) 48.0 ± 3.9 52.6 ± 5.4* 
LVESD (mm) 29.1 ± 4.4 32.3 ± 5.2* 
IVS (mm) 8.8 ± 0.7 11.1 ± 2.2** 
PW (mm) 8.9 ± 0.7 10.8 ± 1.4** 
Values are represented as mean ± SD.  
Abbreviations: EF: ejection fraction; LVEDD: left ventricular end-diastolic diameter; 
LVESD: left ventricular end-systolic diameter; IVS: interventricular septum thickness; PW: 
posterior wall thickness. 
*p < 0.05, **p < 0.0001 vs control. n = 30 in each group. 
 
4.3.3. Electrocardiographic parameters in study subjects 
Comparison of the two groups (acromegalic patients vs control) revealed no significant 
differences in heart rate, the PQ, QRS and QT intervals and the QT dispersion. In order to 
reliably assess the duration of ventricular repolarization and to minimize the influence of 
changing heart rate on the QT interval, frequency corrected QT interval (QTc) was performed 
by the Bazett’s, Fridericia, Framingham and Hodges formulas. QTc values calculated with all 
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the four formulas showed no significant differences between acromegalic patients and 
controls. However, the Tpeak-Tend interval was significantly increased in acromegalic 
patients compared to controls (Table 10). Electrocardiographic parameters tended to be 
shorter in active acromegaly subgroup compared to the data measured in inactive subgroup 
(RR: 859.8 ± 134.5 ms vs 901.0 ± 178.2 ms, not significant (NS), QT: 392.7 ± 28.5 ms vs 
412.0 ±29.5 ms, NS; QTc Bazett’s: 425.0 ± 16.0 ms vs 436.8 ±20.3 ms, NS; QTc Fridericia: 
413.7 ± 15.6 ms vs 428.1 ±16.6 ms, p = 0.0220; QTc Framingham: 414.3 ± 14.9 ms vs 427.3 
±17.8 ms, p = 0.0376; QTc Hodges: 412.5 ± 15.4 ms vs 426.9 ±16.7 ms, p = 0.0209; Tpeak-
Tend: 86.0 ± 15.7 ms vs 84.7 ±11.0 ms, NS, respectively). 
 
Table 10. Electrocardiographic parameters in patients with acromegaly and age-
matched controls 
 
   Control Acromegaly 
RR (ms) 840.0 ± 75.0 877.6 ± 153.4 
PQ (ms) 158.2 ± 17.7 158.0 ± 17.3 
QRS (ms) 92.2 ± 6.5 95.3 ± 8.4 
QT (ms) 389.3 ± 16.5 401.1 ± 30.0 
QTc (ms) Bazett 425.6 ± 17.3 430.1 ± 18.6 
QTc (ms) Fridericia 413.1 ± 14.5 419.9 ± 17.4 
QTc (ms) Framingham 414.0 ± 13.7 419.9 ± 17.2 
QTc (ms) Hodges 410.4 ± 13.8 418.7 ± 17.3 
QTd (ms) 36.6 ± 10.2 38.2 ± 13.2 
Tpeak-Tend (ms) 80.0 ± 10.3 85.5 ± 13.6* 
STVQT (ms) 3.02 ± 0.80 4.23 ± 0.10** 
Values are represented as mean ± SD. 
Abbreviations: QTc: frequency corrected QT interval (calculated by the Bazett’s, Fridericia, 
Framingham and Hodges formulas); QTd: QT dispersion; Tpeak-Tend: duration of the T 
wave from the peak to the end; STVQT: short-term beat-to-beat temporal variability of QT 
interval. 
*p < 0.05, **p < 0.001 vs control. n = 30 in each group. 
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4.3.4. Short-term beat-to-beat temporal variability of the QT intervals 
To characterize the instability of cardiac ventricular repolarization, the short-term beat-to-beat 
variability of the QT interval was calculated in acromegalic patients and age-matched 
controls. As individual representative examples (Poincaré plots, Figure 10) and grouped 
average data show STVQT was significantly increased by 36% in acromegalic patients 
compared to controls (4.23 ± 0.10 ms vs 3.02 ± 0.80 ms, p < 0.001) (Figure 11). STVQT 
values did not differ significantly between active (4.16 ± 0.89 ms) and inactive (4.33 ± 1.22 
ms) acromegalic patient subgroups. There was no difference between acromegalic subjects 
treated with antihypertensive drugs (4.33 ± 0.95 ms, n = 18) and normotensive acromegalic 
patients (4.10 ± 1.16 ms, n = 12). We could not find any significant correlation between the 
STVQT values and the left ventricular hypertrophy parameters in acromegaly patients or in the 
subgroups of active and inactive patients (data not shown). 
 
Figure 10. Representative Poincaré plots of a control individual and a patient with 
acromegaly 
 
Note the larger area covered by data points obtained in the acromegalic patient illustrating 
increased short-term variability of the QT interval.  
Abbreviations: QTc: frequency corrected QT interval (calculated by the Bazett’s formula); 
STVQT: short-term beat-to-beat temporal variability of the QT interval. 
 
 
 
 28 
Figure 11. Short-term beat-to-beat temporal variability of the QT interval (STVQT) in 
acromegalic and matched control patients 
 
Individual values measured in n = 30 patients in each group are presented, the blue lines 
indicate mean values, p < 0.001. 
Abbreviation: STVQT: short-term beat-to-beat temporal variability of the QT interval. 
 
 
4.3.5. Autonomic function 
Standard cardiovascular reflex tests indicated significant deteriorations in Valsalva ratio (p = 
0.0015), 30/15 ratio (p = 0.0143), and AN score (p = 0.0023) in patients with acromegaly, 
however, no significant differences in systolic blood pressure response after standing up, and 
diastolic blood pressure response after sustained handgrip were detected between the two 
groups (Table 11). AN score was significantly lower in active acromegaly subgroup, than in 
inactive group (2.1 ± 1.7 vs 3.9 ± 2.2; p = 0.0260), whereas other autonomic functions 
measured did not differ significantly in our two acromegalic subgroups (heart rate variation 
during deep breathing: 15.5 ± 6.5 1/min vs 11.9 ± 7.95 1/min; Valsalva ratio: 1.50 ± 0.26 vs 
1.40 ± 0.29; 30/15 ratio: 1.10 ± 0.13 vs 1.10 ± 0.29; systolic blood pressure fall after standing 
up: 8.6 ± 11.8 mmHg vs 9.8 ± 6.2 mmHg; diastolic blood pressure increase after handgrip: 
19.1 ± 8.2 mmHg vs 15.4 ± 8.2 mmHg; respectively). There was no significant difference 
between the values of autonomic parameters measured in acromegalic subjects treated with 
antihypertensive drugs and normotensive patients with acromegaly. 
 
 
 
 
 29 
Table 11. Autonomic neuropathy parameters of acromegalic patients and age-matched 
control subjects 
   Control Acromegaly 
Heart rate variation during deep breathing (1/min) 17.20 ± 6.44 14.00 ± 7.22 
Valsalva ratio 1.70 ± 0.34 1.40 ± 0.28* 
30/15 ratio 1.20 ± 0.18 1.10 ± 0.21* 
Systolic BP fall after standing up (mmHg) 6.40 ± 6.77 9.10 ± 9.66 
Diastolic BP increase after sustained handgrip (mmHg) 20.00 ± 9.22 17.50 ± 8.2 
AN score 1.50 ± 1.28 2.90 ± 2.11* 
Values are represented as mean ± SD.  
Abbreviations: 30/15 ratio: immediate heart rate response to standing; BP: blood pressure; 
AN: autonomic neuropathy. 
*p < 0.05 vs control. n = 30 in each group.  
 
4.3.6. Correlation of serum hGH and IGF-1 x ULN levels with cardiovascular data and 
autonomic neuropathy parameters 
Pearson coefficient values indicated that neither hGH nor IGF-1 x ULN hormone level 
correlated with STVQT or any other ECG parameters measured (Table 12). However, serum 
hGH concentration negatively correlated with diastolic blood pressure (p = 0.0326), thickness 
of posterior wall of left ventricle (p = 0.0333), and AN score (p = 0.0131), whereas IGF-1 x 
ULN levels positively correlated with Valsalva ratio (p = 0.0087). 
 
Table 12. Correlation of serum average hGH and IGF-1 x ULN level of acromegalic 
patients with cardiovascular data and autonomic neuropathy parameters 
 
Serum average hGH level 
(ng/ml) Serum IGF-1 x ULN level 
 Pearson r p value  (two-tailed) Pearson r 
p value  
(two-tailed) 
Systolic BP (mmHg) - 0.2294 0.2313 0.3206 0.0900 
Diastolic BP (mmHg) - 0.3978 0.0326* 0.1256 0.5161 
EF (%) 0.3170 0.0878 -0.1735 0.3593 
LVEDD (mm) - 0.2911 0.1186 -0.1680 0.3749 
LVESD (mm) - 0.3507 0.0574 -0.1076 0.5716 
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IVS (mm) - 0.2714 0.1469 0.0388s 0.8387 
PW (mm) - 0.3897 0.0333* 0.1048 0.5815 
RR (ms) - 0.1204 0.5262 - 0.1045 0.5826 
PQ (ms) - 0.1968 0.2974 - 0.0284 0.8817 
QRS (ms) - 0.0127 0.9468 - 0.3023 0.1044 
QT (ms) - 0.2032 0.2815 - 0.2360 0.2092 
QTc (ms) Bazett - 0.1090 0.5663 - 0.2084 0.2690 
QTc (ms) Fridericia - 0.1992 0.2914 - 0.2919 0.1175 
QTc (ms) Framingham - 0.1834 0.3320 - 0.2690 0.1506 
QTc (ms) Hodges - 0.2154 0.2530 - 0.2975 0.1103 
QTd (ms) 0.1562 0.4099 0.1758 0.3526 
Tpeak-Tend (ms) - 0.0917 0.6298 - 0.0788 0.6791 
STVQT (ms) - 0.3401 0.0659 - 0.0924 0.6272 
Heart rate variation 
during deep breathing 
(1/min) 
0.2300 0.2390 - 0.1267 0.5206 
Valsalva ratio 0.1340 0.4967 0.4864 0.0087* 
30/15 ratio 0.2386 0.2307 0.0167 0.9342 
Systolic BP fall after 
standing up (mmHg) - 0.3617 0.0586 - 0.2206 0.2593 
Diastolic BP increase 
after sustained 
handgrip (mm Hg) 
0.2421 0.2146 - 0.0762 0.6998 
AN score - 0.4714 0.0131* - 0.2077 0.2987 
Values are represented as Pearson correlation coefficient (r) and p values.  
Abbreviations: hGH: human growth hormone; IGF-1: insulin-like growth factor-1; ULN: 
upper limit of normal value; BP: blood pressure; EF: ejection fraction; LVEDD: left 
ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; IVS: 
interventricular septum thickness; PW: posterior wall thickness; QTc: frequency corrected QT 
interval (calculated by the Bazett’s, Fridericia, Framingham and Hodges formulas); QTd: QT 
dispersion; Tpeak-Tend: duration of the T wave from the peak to the end; STVQT: short-term 
beat-to-beat temporal variability of QT interval; 30/15 ratio: immediate heart rate response to 
standing; AN: autonomic neuropathy. 
*p < 0.05 for correlation. n = 30 for each number of XY pairs. 
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5. Discussion 
5.1. Electrophysiological background 
In series of animal experiments, in dogs with chronic AV block, myocardial hypertrophy and 
downregulation of potassium channels, most notably of the slow component of the delayed 
rectifier potassium current (IKs), develop [Vos et al. 1998; Nuss et al. 1999; Volders et al. 
1999; Li et al. 2002; Rose et al. 2005]. These animals are more susceptible to lethal 
ventricular arrhythmias subjected to various challenges [Vos et al. 1998]. IKs has been 
identified as a key component in the somewhat redundant repolarizing capacity of the 
myocardium, termed repolarization reserve [Roden 1998; Varró et al. 2000; Roden and Yang 
2005; Roden 2006; Jost et al. 2007]. Repolarization reserve refers to the heart’s compensating 
ability for loss or impaired function of one or more potassium currents critical for normal 
repolarization [Roden 1998]. Impaired repolarization reserve does not necessarily lead to 
clinically manifest repolarization abnormalities on the ECG but makes the heart more 
susceptible to arrhythmia development [Roden 1998; Roden and Yang 2005; Varró and Papp 
2006].  
 It is well established that there are marked transmural and regional differences in the 
expression of cardiac transmembrane ion channels, including potassium channels, that create 
some spatial heterogeneity of repolarization already in normal circumstances [Antzelevitch 
and Fish 2001; Gaborit et al. 2007]. These differences in repolarization, also called dispersion 
and/or heterogeneity of repolarization, can be significantly enhanced by impaired 
repolarization reserve, thus creating an arrhythmia substrate [Varró and Baczkó 2010]. It 
should be emphasized that the creation of an arrhythmia substrate, i.e. the increased 
repolarization heterogeneity following repolarization prolongation, is not enough in itself to 
precipitate arrhythmias. A trigger extrasystole critically timed to the vulnerable period that 
can travel re-entry paths is also required for arrhythmia induction. Enhanced repolarization 
heterogeneity results in longer vulnerable periods and with more frequent extrasystoles the 
chance for serious arrhythmia generation is greater (Figure 12) [Varró and Baczkó 2010]. 
Development of TdP via this mechanism was demonstrated by Akar and co-workers [Akar et 
al. 2002] in dog ventricular wedge preparations, where increased transmural heterogeneity of 
repolarization was found and TdP incidence depended on both bradycardia and administration 
of an IKr blocker. 
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Figure 12. Proposed mechanism of arrhythmia development due to increased 
repolarization heterogeneity 
 
The illustration is represented by exaggerated action potential duration differences. 
In the normal setting, sinus impulses (black arrows) travel via physiological pathways. Early 
extrasystoles („triggers”) propagate in directions (red arrows) where propagation is not 
blocked by refractoriness and where action potentials are in their vulnerable periods (1, 3, 4, 
6), while conduction is blocked in refractory cells (2 and 5). The extra stimulus can travel 
back to its site of origin, creating a re-entry pattern (7). From Varró and Baczkó 2010, with 
permission. 
Abbreviations: SR: sinus rhythm; ERP: effective refractory period, ES: extrasystole. 
 
 
The downregulation of repolarizing potassium currents, including the IK1,Ito,IKr and IKs 
has also been shown both in animal models and patients with heart failure, leading to 
prolonged repolarization manifested as QT prolongation on the surface ECG [Beuckelmann et 
al. 1993; Tomaselli and Marban 1999; Li et al. 2004] and increased dispersion of 
repolarization with concomitant increase in the incidence of serious ventricular arrhythmias 
[Tomaselli et al. 1994; Akar and Rosenbaum 2003; Tamargo et al. 2004; Jost et al. 2007]. 
Increased action potential prolongation favors increased Ca2+ influx that in turn can facilitate 
delayed afterdepolarization (DAD) and arrhythmia development [Bers et al. 2006]. 
Prolongation of repolarization can also precipitate serious ventricular re-entry type 
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arrhythmias via promoting early afterdepolarization (EAD) generation [Zeng and Rudy 1995; 
Michael et al. 2009; Farkas and Nattel 2010]. It might be plausible that myocardial 
hypertrophy, whatever the underlying cause, may lead to potassium channel downregulation 
and may result in decreased repolarization reserve and increased propensity for arrhythmias 
including Torsades de Pointes, a characteristic arrhythmia that can degenerate into ventricular 
fibrillation and culminate in sudden cardiac death. 
 The reliable identification of patients at risk for serious ventricular arrhythmia and 
sudden cardiac death remains elusive. Accumulating evidence suggests that QT interval 
prolongation alone cannot reliably predict the development of TdP since cardiac 
repolarization reserve may be reduced without significant changes in the duration of cardiac 
repolarization. A number of clinical studies [Hinterseer et al. 2008; Hinterseer et al. 2009; 
Hinterseer et al. 2010] and data from in vivo animal experiments using species that are 
electrophysiologically relevant for humans in regard of ventricular repolarization [Thomsen et 
al. 2005; Lengyel et el. 2007; Thomsen et al. 2007; Hanton et al. 2008] as well as in vitro 
studies [So et al. 2008; Abi-Gerges et al. 2010; Szentandrássy et al. 2015] strongly suggest 
that the short-term variability of the duration of repolarization (i.e. QT interval on the ECG) 
may be a better novel parameter to predict serious ventricular arrhythmias. These studies 
found that increased STVQT correlated with elevated incidence of lethal ventricular 
arrhythmias and sudden cardiac death. Therefore, based on these studies and the present 
results, the elevated temporal beat-to-beat variability may indicate a larger repolarization 
instability and an increased propensity for ventricular arrhythmias.  
 The heterogeneity or variability of ventricular repolarization can be characterised by 
spatial (transmural) or temporal (beat-to-beat) dispersion of the action potential duration 
(APD) (Figure 13). The spatial or transmural heterogeneity of repolarization is achieved by 
different electrophysiological properties (different APDs) of myocardial cells (e.g. Purkinje 
fibers, M-cells, epi- or endocardial cells). Clinically, on surface ECG, QT dispersion (QTd; 
the range measured as the maximum – minimum QT interval in all leads of the 12-lead ECG) 
is considered to be an indirect measurement of spatial heterogeneity or dispersion of 
ventricular repolarization. The variability of cardiac repolarization can also be determined as 
temporal or beat-to-beat variability, which means beat-to-beat alternation of the APD 
measured in vitro in a certain myocardial region. Clinically, the short-term beat-to-beat 
variability (STV) can be defined as the alternation (variability) of several (in the present study 
30) consecutive QT intervals measured in a certain lead (in the present study in lead II) of 
surface ECG (Figure 14). 
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Figure 13. Difference between spatial and temporal dispersion of repolarization 
 
                                                                                                 With permission of Varró A. 
 
 
Figure 14. Short-term beat-to-beat temporal variability (STV) of repolarization, as a 
novel measurable parameter of repolarization reserve 
 
                                                                                                     With permission of Varró A. 
Abbreviations: STV: short-term beat-to-beat temporal variability; ECG: electrocardiogram. 
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5.2. Short-term variability of the QT interval in professional soccer players 
In competitive athletes, the cardiovascular system adapts to chronic physical exercise by the 
development of ‘‘athlete’s heart’’, characterized by lower resting heart rate (increased vagal 
tone), increased ventricular mass (hypertrophy) and volume to meet the increased demand. 
 It should be noted that autonomic and cardiac electrophysiological changes in dogs 
with chronic AV block [Volders et al. 1999] possibly do not exactly mirror those developing 
in athlete’s heart, however, few animal experimental data are available on the effect of 
endurance exercise training on cardiac hypertrophy and electrophysiology in species that are 
highly relevant to human, i.e. not in mice and rats. Some of these studies observed slowed 
heart rate, prolonged QT interval and ECG signs of cardiac hypertrophy in such animals 
[Constable et al. 1994; Constable et al. 2000]. Whether a ventricular electrical remodeling 
leading to decreased repolarization reserve develops in these animals is not known, however, 
it has been speculated that in top endurance athletes, downregulation of potassium channels 
might occur [Hart 2003].  
Based on autopsy findings, hypertrophic cardiomyopathy (HCM) is the most common 
cause of SCD in young athletes [Basavarajaiah et al. 2008]. This familial malformation leads 
to cardiac hypertrophy, cardiomegaly and interstitial fibrosis, and it is due to mutations 
identified in a number of sarcomeric genes [Maron 2002]. In athletes, it is quite difficult to 
distinguish normal compensatory cardiac hypertrophy from HCM, and only following a 2-3 
month sports activity-free period can echocardiographic studies reliably identify HCM, since 
this hypertrophy is irreversible [Calderón Montero et al. 2007; Williams et al. 2009]. There 
are a number of other cardiac diseases and pathologies that have been associated with SCD in 
athletes, including arrhythmogenic right ventricular cardiomyopathy, congenital coronary 
artery anomalies, myocarditis, commotio cordis, aortic stenosis, Wolff-Parkinson-White and 
Brugada syndromes [Basso et al. 2007; Pigozzi and Rizzo 2008], however, these are mostly 
identified upon autopsy. 
As mentioned above, there are two main prerequisites for the development of TdP 
chaotic ventricular tachycardia and consequent fatal ventricular fibrillation: an arrhythmia 
substrate (prolonged repolarization, spatial and temporal inhomogeneity of repolarization 
creating re-entry paths) and a trigger (extrasystole in the vulnerable period) for the initiation 
of the arrhythmic event [Varró and Baczkó 2010]. Increased vagal tone in athletes lowers 
heart rate that favors prolonged repolarization and increased inhomogeneity [Farkas et al. 
2008]. The possible potassium channel downregulation due to myocardial hypertrophy also 
prolongs repolarization and reduces repolarization reserve. Theoretically, in this scenario a 
 36 
number of conditions, compounds and dietary constituents can precipitate such events of 
sudden cardiac death (as recently reviewed by Varró and Baczkó) [Varró and Baczkó 2010]. 
These may include serum electrolyte changes (e.g. hypokalemia when fluid intake is not 
adequate), food and drinks containing flavonoids with hERG (human ether-à-go-go-related 
gene) inhibitory effects [Zitron et al. 2005], medications with various degree of hERG and 
other potassium channel blocking properties. These factors can create and enhance the 
arrhythmia substrate in athletes, while elevated intracellular cyclic adenosine monophosphate 
(cAMP) levels due to increased sympathetic discharge may contribute to trigger extrasystole 
generation via increased pacemaker (If) current [DiFrancesco and Borer 2007] and/or 
increased L-type calcium current [Sperelakis et al. 1996]. 
 In conclusion, the short-term temporal variability of the QT interval is elevated in 
professional soccer players, which, according to our present knowledge, might indicate 
increased repolarization instability even without any underlying cardiac disease. In our study, 
some soccer players exhibited greatly increased STVQT even when compared to other players, 
suggesting that it may be beneficial to screen athletes for elevated repolarization instability by 
adding the relatively low cost STVQT determination to routine ECG examinations. Individual 
athletes with large STVQT could be then subjected to more detailed and sophisticated 
examinations (e.g. evaluation of possible mutations in potassium channel protein encoding 
genes) to carefully evaluate their vulnerability to ventricular arrhythmias and sudden cardiac 
death. Importantly, our results further support the inclusion of ECG in preparticipation athlete 
screening expertly worked out by Corrado et al. [Corrado et al. 2008], with the notion that 
calculation of STVQT could also be added to the ECG evaluation in case our findings can be 
confirmed in a broader athlete population. It is important to emphasize that no arrhythmias 
were observed among soccer players in this study and further, more comprehensive 
investigations are needed to establish whether the higher STVQT relates to higher arrhythmia 
propensity in this population.  
 
Study limitations 
For purely practical and logistic reasons echocardiographic assessment of all soccer players 
and all controls were not performed in this study. However, our echocardiography data 
randomly performed on 23 soccer players and 23 controls support the findings of a number of 
previous studies showing that endurance athletes, including soccer players, as part of the 
cardiovascular system’s physiological response to long-term intense physical training, 
develop athlete’s heart that features myocardial hypertrophy [Shapiro 1984; Scharhag et al. 
 37 
2002; Abernethy et al. 2003; Atchley and Douglas 2007; Paolo and Pelliccia 2007]. In our 
study, professional soccer players from the first division were enlisted who participated in 
rigorous endurance training schedule for years based on international standards. We also 
found they had significantly decreased resting heart rate and consequent prolongation of the 
QT interval, both are characteristics of athlete’s heart. Based on the above it is assumed that 
the echocardiography data are representative for their respective groups. 
 Since the duration of repolarization is cycle length dependent, variability in the RR 
interval could influence QT variability. Based on our results, the influence of STVRR on 
STVQT cannot be ruled out, however, in professional soccer players STVRR was reduced and 
was similar to control values after the competitive game while STVQT remained significantly 
higher; strongly suggesting that STVQT was increased irrespective of changes in STVRR. The 
short-term variability of the monophasic action potential was found to be partially influenced 
by pacing cycle length and was moderately decreased at faster cycle lengths in anesthetized 
dogs with chronic AV block characterized by marked bradycardia and myocardial 
hypertrophy [Thomsen et al. 2005].  
 
5.3. Short-term variability of the QT interval and correlation with parameters of left  
       ventricular hypertrophy in patients with hypertrophic cardiomyopathy 
Hypertrophic cardiomyopathy is characterized by morphological and structural changes, 
including left ventricular hypertrophy, myocardial fibrosis, myofiber disarray, and small 
vessel disease among them, that may represent an arrhythmogenic substrate of the disease 
[Maron 2002]. Remodeling in HCM is a progressive process [Olivotto et al. 2012] and a very 
recent study highlighted a close correlation between the development of adverse remodeling 
and increased risk for SCD in HCM patients [Vriesendorp et al. 2014]. In chronic heart 
failure, structural remodeling is accompanied by electrical remodeling that includes profound 
changes in the expression of voltage gated depolarizing and repolarizing ionic currents and 
exchangers resulting in decreased cardiomyocyte repolarizing capacity [Nattel et al. 2007]. 
This decreased repolarizing capacity can be brought about by an increase in depolarizing 
currents (Na+ and Ca2+) and decreased potassium channel densities (particularly IK1, Ito and 
IKs), resulting in action potential prolongation manifested as QT prolongation on the ECG 
[Beuckelmann et al. 1993; Tomaselli and Marban 1999; Li et al. 2004].  
A particularly interesting observation is the increase in slowly inactivating, late 
sodium current (INa,late), that has been shown to prolong repolarization in heart failure and also 
to contribute to arrhythmogenesis [Valdivia et al. 2005]. Most interestingly, these elements of 
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arrhythmogenic electrical remodeling have not only been described in congestive heart failure 
and pathologies leading to cardiac hypertrophy, but a very recent study identified similar 
changes in cardiomyocytes isolated from HCM patients [Coppini et al. 2013]. The decreased 
repolarization capacity due to HCM leads to markedly impaired repolarization reserve [Varró 
and Baczkó 2011] and increased arrhythmia susceptibility in HCM, where even drugs or 
dietary constituents with only mild repolarization inhibitory effects can provoke serious 
ventricular arrhythmias and SCD. 
 QT variability has been previously shown to be increased in patients with HCM. The 
normalized QT variability index (QTVI), measured as described by Berger et al, was shown 
to be higher in HCM patients than in controls [Atiga et al. 2000], and the greatest abnormality 
was detected in patients with malignant HCM mutations (i.e. Arg403Gln mutation of the beta 
myosin heavy chain gene). In a recent paper [Magri et al. 2014] several myocardial 
repolarization parameters, including normalized QT variability (QTVN) and normalized QT 
variability index (QTVI) were shown to be associated with the presence and extent of late 
gadolinium enhancement (LGE) detected on cardiac magnetic resonance in patients with 
hypertrophic cardiomyopathy. Both QTVN and QTVI were higher in patients with LGE. 
Among other parameters, the extent of LGE and sudden cardiac death risk factor burden (the 
number of traditional risk factors for sudden cardiac death) predicted QTVI. Of note, left 
ventricular mass index was also associated with QTVN. However, QTVI or QTVN provide a 
measure of overall QT variability measured during the whole duration of the ECG recording 
and does not take into account beat-to-beat variations, which might be equally, or even more 
important. 
 In our work, STVQT showed correlation with different indices of LV hypertrophy. 
Myocardial hypertrophy is an inherent feature of HCM, the magnitude of which is shown to 
be related to adverse cardiac events, including sudden cardiac death, in patients with HCM 
[Spirito et al. 2000]. Indeed, pronounced myocardial hypertrophy, defined as left ventricular 
wall thickness >30 mm is an independent predictor for SCD in HCM, and a prophylactic ICD 
implantation for primary SCD prevention is suggested in such cases by current clinical 
guidelines [Gersh et al. 2011]. Left ventricular mass, measured by MRI, might be an even 
stronger predictor for such adverse events, as markedly increased LV mass index was proved 
to be more sensitive with regard to HCM-related death, than maximal wall thickness [Olivotto 
et al. 2008]. It is of note that ECG voltage parameters, indicating the magnitude of myocardial 
hypertrophy, also correlates with adverse events in HCM [Ostman-Smith et al. 2010]. 
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Study limitations 
The study was not designed to assess link between QT variability and increased risk of 
sudden cardiac death. With this regard, it would be necessary to prove that increased STVQT 
is directly linked to SCD risk in HCM. Initially, it would be important to show whether 
STVQT correlates with other established parameters defining increased SCD risk (occurrence 
of syncope, abnormal blood pressure response during exercise, non-sustained ventricular 
tachycardia (NSVT) on 24-hour Holter recording, etc.). Further, a direct association of STVQT 
with SCD should be tested in a large patient cohort with HCM in a multivariate analysis. 
 
5.4. Short-term variability of QT interval in patients with acromegaly 
Cardiac rhythm abnormalities have been demonstrated by electrocardiogram and Holter 
studies in acromegaly [Colao et al. 2004; Rhee and Pearce 2009]. Resting electrocardiological 
changes included left axis deviation, increased QT intervals, septal Q-waves, ST-T wave 
depression, and late potentials in acromegalic patients [Rodrigues et al. 1989; Herrmann et al. 
2001]. Atrial and ventricular ectopic beats, paroxysmal atrial fibrillation, paroxysmal 
supraventricular tachycardia, sick sinus syndrome, bundle branch block, and ventricular 
tachycardia were seen during physical exercise [Colao et al. 2004; Rhee and Pearce 2009]. 
The severity of ventricular arrhythmias correlated with increases in left ventricular mass and 
the frequency of ventricular premature complexes increased with the duration of acromegaly 
[Kahaly et al. 1992]. Fatti et al. [Fatti et al. 2006] detected abnormally long QTc interval 
before treatment in one-quarter of 30 acromegalic patients in a retrospective study. 
 Acromegalic cardiomyopathy is frequently present at diagnosis and the majority of 
patients with acromegaly meet echocardiographic criteria for left ventricular hypertrophy 
[Rhee and Pearce 2009]. A possible reason is that acromegalic patients are sometimes 
diagnosed only after longer duration (7–10 years) of the disease. No significant difference in 
left ventricle hypertrophy was observed between active and inactive acromegalic patients in 
our study, which may indicate that adequate treatment of acromegaly could not turn back the 
process. Cardiac performance of acromegalic patients during physical exercise depends on 
left ventricular diastolic function under resting condition [Spinelli et al. 2003]. Ciulla et al. 
[Ciulla et al. 1999] found elevated myocardial echoreflectivity and increased QTd in 
acromegalic patients and explained these changes by long-term, blood pressure-independent 
cardiac hypertrophy and prolonged exposure to high serum concentrations of hGH and IGF-1. 
 Patients with acromegaly may also develop congestive heart failure, the ratio was less 
than 3% (10 of 330 consecutive patients) in a study performed in 2 centers [Bihan et al. 
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2004]. Recent studies indicated that IKs, IKr, IK1 and Ito potassium channels were down-
regulated [Kääb et al. 1998; Näbauer and Kääb 1999; Li et al. 2002] and the persistent or 
slowly-inactivating sodium current was also increased in chronic heart failure [Valdivia et al. 
2005]. Additionally, acromegalic patients could also develop coronary heart disease and most 
patients have systemic complications affecting the Framingham risk score [Bogazzi et al. 
2007]. hGH receptor antagonist therapy improved the score and reduced the risk for coronary 
heart diseases [Berg et al. 2010]. It should be noted that myocardial fibrosis occurring in 
acromegaly [Lie 1980] can also contribute to the underlying arrhythmia substrate in the heart 
due to disturbances in conduction. 
 Our observations indicate deterioration in autonomic function assessed by standard 
cardiovascular reflex tests in acromegalic patients. AN score was significantly worse in 
inactive acromegalic patients and there was no apparent difference between acromegalic 
subgroups in other autonomic parameters measured, which may suggest that these neuropathy 
parameters are long-term consequences of acromegaly and cannot be reverted by the control 
of the disease. Among the tests primarily reflecting parasympathetic functions, the Valsalva 
ratio and 30/15 ratio were significantly decreased in acromegaly, whereas heart rate variation 
during deep breathing was not changed significantly. The tests demonstrating sympathetic 
activity, such as systolic blood pressure fall after standing up and diastolic blood pressure 
increase after sustained handgrip, did not change significantly in acromegalic patients. These 
reflex tests indicate a moderate parasympathetic dysfunction in our study, which could 
represent a predisposition to proarrhythmic activity in acromegalic patients. Increased risk of 
sudden cardiac death and ventricular arrhythmia has been associated with decreased 
parasympathetic and increased sympathetic activity [Lahiri et al. 2008]. Parasympathetic 
activation has been considered as antiarrhythmic regarding the development of ventricular 
fibrillation in pathological settings; for a recent review see [Shen and Zipes 2014].  
 In conclusion, STVQT is increased in patients with acromegaly while more 
conventional parameters of ventricular repolarization were unchanged. STVQT values did not 
differ between active and inactive acromegalic patients and did not correlate with actual 
serum concentrations of hGH and IGF-1. These observations may suggest that elevated short-
term beat-to-beat variability is a consequence of the disease and not related directly to current 
treatment or condition of the patient. The elevated STVQT suggests instability of ventricular 
repolarization and may be an early indicator of increased liability to arrhythmia in patients 
with acromegaly. Further prospective clinical studies are needed to identify individual risk for 
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ventricular arrhythmias in acromegalic patients. 
 
Study limitations  
It is important to note that in the present study the duration of acromegaly from the diagnosis 
can be defined (10–30 years), however the exact onset of the disease is not determinable and 
furthermore the duration since the remission in the inactive acromegalics is also not known. 
Therefore the real exposure time of increased hGH level before the diagnosis and effective 
treatment of the disease is not known and our active and inactive patients groups can be 
heterogenous in this regard. Moreover, the actual hormone levels used for correlation 
calculations with echocardiography and other cardiovascular parameters do not necessarily 
correspond to the duration of the disease. Because of our unexpected negative correlation 
between the hGH level and the posterior wall thickness, further echocardiographical studies 
are warranted to examine the relationship between hGH and IGF-1 levels and 
echocardiographic parameters in a larger series of acromegalic patients. A prospective study 
on newly diagnosed acromegaly patients could answer the question whether effective 
treatment would have any time-related effects on the changes in STVQT variability and 
autonomic cardiovascular functions. 
 
6. New observations and conclusions 
 
1. The main and novel finding of this study is that short-term beat-to-beat temporal variability 
of the QT interval (STVQT) is significantly increased in professional soccer players compared 
to age-matched healthy volunteers. The increased STVQT was accompanied by a prolonged 
QT, and a lengthened frequency corrected QT interval calculated by Fridericia and Hodges 
formulas in these athletes. 
 
2. In this study we also found that all ECG repolarization parameters, including frequency 
corrected QT interval, QT dispersion, short-term beat-to-beat temporal variability of QT 
interval and the duration of the T wave from the peak to the end (Tpeak-Tend) were 
significantly increased in patients with hypertrophic cardiomyopathy. STVQT exhibited the 
largest relative increase among the different parameters and also showed the best correlation 
with indices of left ventricular hypertrophy, i.e. maximal left ventricular wall thickness or 
magnetic resonance imaging derived left ventricular mass, indexed or unindexed for body 
surface area. 
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3. Although a connection between acromegaly and increased cardiovascular morbidity and 
mortality was established previously, this study is the first to demonstrate increased short-
term beat-to-beat temporal variability of the QT interval in acromegalic patients. There was 
no significant difference between STVQT values measured in clinically and biochemically 
active acromegalic patients and those in inactive patients, which may suggest that elevated 
STVQT is related to the presence of acromegaly and not to the efficacy of the treatments 
applied. 
 
4. In this study, we showed that a novel parameter of repolarization instability, the short-term 
beat-to-beat variability of the QT interval, is increased in cardiac hypertrophy initiated by 
different clinical conditions: competitive sport training, hypertrophic cardiomyopathy or 
acromegaly. 
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Abstract
Background: Sudden cardiac death in competitive athletes is rare but it is significantly more frequent than in the normal
population. The exact cause is seldom established and is mostly attributed to ventricular fibrillation. Myocardial hypertrophy
and slow heart rate, both characteristic changes in top athletes in response to physical conditioning, could be associated
with increased propensity for ventricular arrhythmias. We investigated conventional ECG parameters and temporal short-
term beat-to-beat variability of repolarization (STVQT), a presumptive novel parameter for arrhythmia prediction, in
professional soccer players.
Methods: Five-minute 12-lead electrocardiograms were recorded from professional soccer players (n = 76, all males, age
22.060.61 years) and age-matched healthy volunteers who do not participate in competitive sports (n = 76, all males, age
22.060.54 years). The ECGs were digitized and evaluated off-line. The temporal instability of beat-to-beat heart rate and
repolarization were characterized by the calculation of short-term variability of the RR and QT intervals.
Results: Heart rate was significantly lower in professional soccer players at rest (6161.2 vs. 7261.5/min in controls). The QT
interval was prolonged in players at rest (41963.1 vs. 39063.6 in controls, p,0.001). QTc was significantly longer in players
compared to controls calculated with Fridericia and Hodges correction formulas. Importantly, STVQT was significantly higher
in players both at rest and immediately after the game compared to controls (4.860.14 and 4.360.14 vs. 3.560.10 ms, both
p,0.001, respectively).
Conclusions: STVQT is significantly higher in professional soccer players compared to age-matched controls, however,
further studies are needed to relate this finding to increased arrhythmia propensity in this population.
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Introduction
Sports activities are undoubtedly beneficial that improve quality
of life and life expectancy, however, a number of tragic athletic
field deaths have been reported in recent years, attracting
widespread media attention. A significant amount of these cases
involved elite professional soccer players [1–3]. Sudden death
among young athletes is rare (1:50 000–1:100 000), however, it is
still 2–4 times more frequent than in age-matched controls [4].
Although a number of congenital and acquired cardiac diseases
have been identified to be in the background of sudden cardiac
death in athletes (for a recent review see Pigozzi and Rizzo) [5],
approximately 5% of SCD cases in athletes no structural
abnormalities were detected in the heart upon autopsy, that is
the heart appeared completely normal [6,7]. The exact mecha-
nism of SCD in these cases is not established and the cause is
mostly attributed to ventricular fibrillation. In case of inconclusive
autopsy findings, an ischemic origin of SCD is often suspected
without hard evidence. In young athletes, SCD usually does not
happen at peak performance, but during warmup, after training,
or during a relatively inactive period of a competitive game, and
ischemia specific signs on the ECG or proof of myocardial
infarction is rarely found during or following these events. In
addition, regular training is considered to lead to cardiac
preconditioning, one of the most powerful cardioprotective
(antiarrhythmic and antiischemic) mechanisms, that would
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18751
significantly increase the chance for survival during these episodes
[8,9]. Therefore, as a cause myocardial ischemia in sudden cardiac
death of young (,35 years) competitive athletes seems unlikely.
Importantly, the scenario is quite different in older (.35 years)
athletes, where ischemia is an important contributor to SCD, as
reviewed by Pigozzi and Rizzo [5]. It should be noted that blunt
trauma to the chest and concomitant cardiac contusion suffered
during a game or training can also lead to electrocardiographic
abnormalities [10] and sudden cardiac death [11].
Physical conditioning in competitive athletes induces cardiovas-
cular adaptation including lower resting heart rate (increased vagal
tone) and increased cardiac mass (hypertrophy) and volume as a
consequence of increased demand on the cardiovascular system,
called ‘‘athlete’s heart’’, a physiological compensatory mechanism
that reverses in most cases following the termination of sports
activities [12]. Echocardiography studies show that myocardial
hypertrophy develops following long-term sports activities [12–14].
The largest increase in left ventricular cavity and wall thickness
(.75%) was measured in cyclists, cross-country skiers, rowers,
football players, and water polo players, while weight lifters, fencers,
and wrestlers exhibited smaller changes (,50%) [15].
Myocardial hypertrophy in pathological settings in humans
[16–18] and in animal models, especially in the chronic
atrioventricular (AV) block dog model [19] and heart failure
models [20–22], has been shown to cause electrophysiological
remodeling where the expression of different ion channels,
including potassium channels critical for repolarization, and
exchangers is altered. In particular, the detected downregulation
of different potassium channels (i.e. IKs, IKr and IK1) in the chronic
AV block dog model has been associated with increased incidence
of serious ventricular arrhythmias probably due to decreased
repolarization reserve [19–23].
Furthermore, the duration of repolarization is cycle length
dependent and low heart rate in athletes leads to prolonged
repolarization. These changes can also be associated with
increased propensity for ventricular arrhythmias, including
Torsades de Pointes (TdP). It is conceivable that prolonged
repolarization, increased spatial dispersion of repolarization and a
possibly impaired repolarization reserve due to myocardial
hypertrophy-induced downregulation of potassium currents might
represent increased risk for the development of ventricular
arrhythmias, including TdP that can degenerate into VF and
lead to sudden cardiac death in athletes.
In theory, if athletes with no apparent structural cardiac
abnormalities but with increased susceptibility for cardiac
arrhythmias could be identified, current screening methods could
be improved to further decrease the incidence of sudden cardiac
death in young athletes. However, current techniques for the
reliable prediction of TdP and other, potentially fatal ventricular
arrhythmias remain unsatisfactory. Based on recent evidence, in
addition to the prolonged QTc interval, the short-term variability
(STV) of repolarization can probably more reliably predict the
development of TdP both in humans [24] and in animal models
with decreased repolarization reserve [25,26], and short-term
variability of repolarization can increase when no noticable
changes in the duration of cardiac repolarization are observed.
Since elevated STV of the QT interval (STVQT) has been
associated with latent repolarization disorders and increased
suspectibility to serious ventricular arrhythmias in LQT patients
and patients with dilated cardiomyopathy [27,28], the aim of this
study was to compare conventional ECG parameters as well as the
short-term beat-to-beat temporal variability of the RR and QT
intervals of professional soccer players to age-matched controls
who do not participate in competitive sports.
Methods
Ethics Statement
The studies described here were carried out in accordance with
the Declaration of Helsinki (2000) of the World Medical
Association and were approved by the Scientific and Research
Ethical Committee of the Medical Scientific Board at the
Hungarian Ministry of Health (ETT-TUKEB), under ethical
approval No. 4987-0/2010-1018EKU (338/PI/010). All subjects
have given written informed consent of the study.
Study Subjects
The study population consisted of 76 male professional soccer
players from the Hungarian Premier League (ages 16 to 39, mean
22.060.61 years; weight 76.260.95 kg, BMI 23.260.18 kg/m2),
and 76 male, age-matched healthy control sedentary subjects who
did not participate in sports activities (age 15 to 39, mean
22.060.54 years; weight 7761.7 kg, BMI 23.360.48 kg/m2).
Professional soccer players or age-matched controls were
excluded from the study if they exhibited an excessive number
(.5%) of ectopic atrial or ventricular beats, were in a rhythm
other than normal sinus rhythm, had repolarization abnormal-
ities (i.e. early repolarization pattern, T wave inversion and
complete LBBB or RBBB), had a permanent pacemaker or had
any other disorder such as serious retinopathy, symptomatic
cardiac and/or pulmonary disease, acute metabolic disease, had
excessive noise on the electrocardiographic signal that precluded
analysis of the ECG waveform, were on any medication likely to
affect the investigated parameters or consumed significant
amount of food within 3 hours or drank alcohol, coffee or
smoked within 10 hours. All of the control individuals and soccer
players were of European descent.
Electrocardiography
Five-minute 12-lead electrocardiograms (lead II) were recorded
from professional soccer players and age-matched healthy human
volunteers using Cardiosys H-01 software (Experimetria Ltd.,
Budapest, Hungary) in the supine position. The ECGs were
digitized and stored on a computer for later analysis. The RR, QT
intervals were measured using automated algorithms as the average
of 30 beats, the frequency corrected QT interval (QTc) was
calculated using Bazett’s (QTc=QT/!RR), Fridericia (QTc=
QT/[RR/1000]1/3), Framingham (QTc=QT+[0.154 * {1000-
RR}]) and the Hodges formulas (QTc=QT+1.75 * [{60 000/
RR}260]).
In athletes, baseline ECG recordings were taken before a
competitive soccer game (Hungarian Premier League) and also
approximately 20 minutes after the end of the game in the
dressing room.
The calculation of the short-term beat-to-beat variability of
repolarization was chosen since it is a relatively simple method that
has been suggested as a future screening tool; moreover it has been
shown in animal studies [25,26] and in certain patient populations
[27,28] to reliably predict increased arrhythmia propensity.
Using 30 consecutive beats, RR and QT intervals were plotted
against their respective previous interval and Poincare´ plots were
constructed as described previously [23]. The instability of beat-to-
beat heart rate and repolarization were characterized by the short-
term variability (STV) of the RR and QT intervals, and were
calculated using the following formula: STV=g|Dn+12Dn|
(306!2)21, where D is the duration of the RR or QT intervals.
This calculation defines the STV as the mean distance of points
perpendicular to the line of identity in the Poincare´ plot.
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Echocardiography
Echocardiographic measurements were performed at rest on 23
professional soccer players and 23 age-matched controls using a
Dornier AI 4800 (Germany) echocardiograph with a 2.5 MHz
transducer. Two-dimensionally guided M-mode recordings were
obtained parasternally in accordance with the recommendations
of the American Society of Echocardiography [29]. Measurements
were carried out as described previously [30]. For purely logistic
reasons, not all control individuals and soccer players were
subjected to echocardiography.
Statistics
Body weight, BMI, age and ECG interval data are expressed as
means 6 standard error of the mean (S.E.M.). Comparisons
between controls and soccer players were made using the unpaired
Student’s t-test. ECG parameters of athletes before and after the
game were compared by one-way analysis of variance (ANOVA)
followed by a paired t-test. A p value of ,0.05 was considered
significantly different. Statistical analyses were performed using
Statistica for Windows (version 9).
Results
Echocardiography measurements in study subjects
Professional soccer players exhibited significantly higher values
in interventricular septum, left ventricular posterior wall thickness
and in left ventricular internal diameter during diastole compared
to age-matched controls (Table 1). These results were not
unexpected and were supportive of the presence of athlete’s heart
in these professional soccer players.
Heart rate, QT and QTc intervals in study subjects
The development of athlete’s heart in response to long-term
physical conditioning is characterized by increased vagal tone. As
expected, the RR intervals in soccer players were significantly
longer before the game compared to age-matched volunteers
(Fig. 1A). Consequently, the heart rate of professional soccer
players were lower compared to the control group before the game
(Fig. 1B). However, after the soccer game the heart rates of athletes
were higher than in controls (Fig. 1B).
The duration of cardiac repolarization is cycle length dependent
where slower heart rates lead to prolonged repolarization.
Accordingly, significantly longer QT intervals and were measured
in soccer players before the game (Fig. 2). However, after the game
these differences in QT intervals were not observed, since heart
rates of athletes were similar to controls, while the QT intervals in
soccer players were significantly shorter than before the game
(Fig. 2.).
In order to reliably assess the duration of ventricular
repolarization and to minimize the influence of changing heart
rate on the QT interval, it is necessary to carry out frequency
correction of the QT interval. However, recent work has shown
that Bazett and Fridericia correction formulas described over 90
years ago [31,32] overestimate changes in QT interval [33].
Therefore, in this study, to calculate the frequency corrected QT
interval (QTc) we also used Framingham and Hodges correction
formulas shown to alter the accuracy of QT interval changes due
to heart rate in a smaller degree [33]. In this regard, QTc
calculated using the Bazett and Framingham formulae were not
different in athletes before the game compared to controls (Fig. 3A
and D), while QTc values calculated with the other two formulas
were significantly longer in players before the game (Fig. 3B and
D). In addition, QTc was significantly prolonged in soccer players
Table 1. Echocardiographic parameters in professional soccer
players and age matched controls.
IVSd (mm) LVPWd (mm) LVIDd (mm) LVIDs (mm)
Controls 9.060.31 9.160.9 48.160.95 31.960.96
Soccer players 10.260.20** 9.960.14** 50.660.80* 33.360.66
IVSd: interventricular septum thickness during diastole; LVPWd: left ventricular
posterior wall thickness; LVIDd, LVIDs: left ventricular internal diameter during
diastole and systole; n = 23 in each group,
*p,0.05,
**p,0.01 vs. control.
doi:10.1371/journal.pone.0018751.t001
Figure 1. The RR interval and heart rate of age-matched
controls and professional soccer players before and following
a competitive game. A: The RR interval was significantly longer (A)
and heart rate was significantly lower (B) in soccer players before the
game compared to controls (n = 76 persons/group; ***p,0.001 vs. age-
matched control; Means6 S.E.M.; ###p,0.001 vs. before game values).
doi:10.1371/journal.pone.0018751.g001
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following the game compared to control values calculated with all
correction formulae in the present study (Fig. 3A–D). Only QTc
calculated with the Bazett formula showed a large and significant
prolongation in soccer players after the game compared to pre-
game values (Fig. 3A–D).
Short term beat-to-beat variability of the RR and QT
intervals
To characterize the instability of cardiac ventricular repolari-
zation, the short-term beat-to-beat variability of the QT interval
was calculated in professional soccer players and age-matched
controls. Since it is reasonable to assume that STVQT can be, at
least in part, influenced by the short-term variability of the RR
interval, the STVRR was also calculated in both groups. Soccer
players before the competitive game exhibited a significantly larger
STVRR compared to controls, however, this difference disap-
peared after the game, when their heart rates were similar to
controls (Fig. 4A).
As individual representative examples (Poincare´ plots) and
grouped average data show, the short-term beat-to-beat variability
of the QT interval was significantly higher in soccer players
compared to controls (Fig. 4B and C). Importantly, and unlike the
STVRR, the STVQT was still significantly higher in soccer players
compared to controls but was also reduced after the game
compared to pre-game values (Fig. 4C). Histograms on Figures 5
and 6 show the distribution of QT interval and STVQT values
within the control and soccer player groups, respectively. The
histograms clearly exhibit a shift to the right in the distribution of
both QT intervals and STVQT in soccer players before the
competitive game compared to controls (Figs. 5A and 6A).
However, while the distribution of QT intervals show a similar
pattern in soccer players to controls following the game (Fig. 5B),
the distribution pattern of STVQT largely remained unchanged
after the game (Fig. 6B). These results suggest that the increased
STVQT in soccer players is very unlikely caused by the prolonged
QT interval itself in these athletes.
In six players before the game the STVQT was markedly larger
than the average STVQT in the soccer player group (9.7, 7.2, 7.0,
7.0, 6.7, 6.7 and group average was 4.860.14 ms; Fig. 6.). Since
increased STVQT has been associated with increased proarrhyth-
mic risk in certain patient populations, the player who had 9.7 ms
STVQT was contacted and the measurement was repeated to yield
a heart rate of 47/min and an STVQT of 5.0 ms, however, before
the repeated measurement he had been injured for 2 months.
Whether this smaller (but still higher and close to the group
average) STVQT on repeated measurement was due to the well-
known de-training phenomenon in an athlete who had been out of
training due to injury was unclear.
Discussion
The main and novel finding of this study is that short-term beat-
to-beat variability of the QT interval is significantly increased in
professional soccer players compared to age-matched healthy
volunteers. The increased STVQT was accompanied by a
prolonged QT, and a lengthened Fridericia and Hodges QTc
interval in these athletes.
In competitive athletes, the cardiovascular system adapts to
chronic physical exercise by the development of ‘‘athlete’s heart’’,
characterized by lower resting heart rate (increased vagal tone),
increased ventricular mass (hypertrophy) and volume to meet the
increased demand.
In a reasonable animal experimental analogue for athlete’s
heart, in dogs with chronic AV block, myocardial hypertrophy and
downregulation of potassium channels, most notably of the slow
component of the delayed rectifier potassium current (IKs),
develops [34]. These animals are more susceptible to lethal
ventricular arrhythmias subjected to various challenges [19]. IKs
has been identified as a key component in the somewhat
redundant repolarizing capacity of the myocardium, termed
repolarization reserve [35,36]. Repolarization reserve refers to
the heart’s compensating ability for loss or impaired function of
one or more potassium currents critical for normal repolarization
[37]. Impaired repolarization reserve does not necessarily lead to
clinically manifest repolarization abnormalities on the ECG but
makes the heart more susceptible to arrhythmia development
[37–39]. The downregulation of repolarizing potassium currents,
including the IK1, Ito, IKr and IKs has also been shown both in
animal models and patients with heart failure, leading to
prolonged repolarization, increased dispersion of repolarization
with concomitant increase in the incidence of serious ventricular
arrhythmias [36,40–42]. It might be plausible that myocardial
hypertrophy, whatever the underlying cause, may lead to
potassium channel downregulation and may result in decreased
repolarization reserve and increased propensity for arrhythmias
including Torsades de Pointes, a characteristic arrhythmia that
can degenerate into ventricular fibrillation and culminate in
sudden cardiac death. It should be noted that autonomic and
cardiac electrophysiological changes in dogs with chronic AV
block possibly do not exactly mirror those developing in athlete’s
heart, however, few animal experimental data are available on the
effect of endurance exercise training on cardiac hypertrophy and
electrophysiology in species that are highly relevant to human, i.e.
not in mice and rats. Some of these studies observed slowed heart
rate, prolonged QT interval and ECG signs of cardiac
hypertrophy in such animals [43,44]. Whether a ventricular
electrical remodeling leading to decreased repolarization reserve
develops in these animals is not known, however, it has been
speculated that in top endurance athletes, downregulation of
potassium channels might occur [45].
There are two main prerequisites for the development of TdP
chaotic ventricular tachycardia and consequent fatal ventricular
fibrillation: an arrhythmia substrate (prolonged repolarization,
Figure 2. The QT intervals of age-matched controls and
professional soccer players before and following a competitive
game. The QT interval was significantly longer in soccer players before
the game (n = 76 persons/group; ***p,0.001 vs. age-matched control;
Means 6 S.E.M.; ###p,0.001 vs. before game values).
doi:10.1371/journal.pone.0018751.g002
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spatial and temporal inhomogeneity of repolarization creating re-
entry paths) and a trigger (extrasystole in the vulnerable period) for
the initiation of the arrhythmic event. Increased vagal tone in
athletes lowers heart rate that favors prolonged repolarization and
increased inhomogeneity. The possible potassium channel down-
regulation due to myocardial hypertrophy also prolongs repolar-
ization and reduces repolarization reserve. In some athletes, loss of
function mutations of repolarizing potassium channels and/or
gain of function mutations of sodium channels may be present. In
these individuals with impaired repolarization reserve, additional,
most likely moderate potassium channel blocking effects can
provoke TdP arrhythmias that, in some cases lead to ventricular
fibrillation. Theoretically, in this scenario a number of conditions,
compounds and dietary constituents can precipitate such events of
sudden cardiac death (as recently reviewed by Varro´ and Baczko´)
[46]. These may include serum electrolyte changes (e.g. hypoka-
lemia when fluid intake is not adequate), food and drinks
containing flavonoids with HERG inhibitory effects [47],
medications with various degree of HERG and other potassium
channel blocking properties. In this regard, the celecoxib has been
shown to block Kv2.1 channels [48]. Non-steroid antiinflamma-
tory drugs are used by athletes very often and in large doses to
treat sports injuries. These factors can create and enhance the
arrhythmia substrate in athletes, while elevated intracellular cAMP
levels due to increased sympathetic disharge may contribute to
trigger extrasystole generation via increased pacemaker (If) current
[49] and/or increased L-type calcium current [50].
The reliable identification of patients at risk for serious
ventricular arrhythmia and sudden cardiac death remains elusive.
Accumulating evidence suggests that QT interval prolongation
alone cannot reliably predict the development of TdP since
cardiac repolarization reserve may be reduced without siginificant
changes in the duration of cardiac repolarization. A number of
clinical studies [27,28,51] and data from in vivo animal experiments
using species that are electrophysiologically relevant for humans in
regard of ventricular repolarization [26,52–54] as well as in vitro
studies [55,56] strongly suggest that the short-term variability of
the duration of repolarization (i.e. QT interval on the ECG) may
Figure 3. Frequency corrected QT interval of age-matched controls and professional soccer players before and following a
competitive game. QTc interval calculated with the Bazett formula was not different in soccer players before the game and was significantly
prolonged after the game (A). QTc values calculated with the Fridericia and Hodges formulae but not the Framingham formula showed significant
difference between groups before the game, and none of the three calculations yielded any difference between before and after game values in
soccer players (B, C and D; n = 76 persons/group; Means 6 S.E.M.; *p,0.05; **p,0.01; ***p,0.001 vs. age-matched control; ###p,0.001 vs. before
game values).
doi:10.1371/journal.pone.0018751.g003
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be a better novel parameter to predict serious ventricular
arrhythmias. These studies found that increased STVQT correlat-
ed with elevated incidence of lethal ventricular arrhythmias and
sudden cardiac death. Importantly, the patients and experimental
animals in all of these studies had narrowed repolarization reserve,
albeit due to different mechanisms, ranging from pharmacological
inhibition of repolarizing potassium channels to downregulation of
potassium currents during electrical remodeling and including
mutations in ion channels leading to congenital long QT
syndromes. Therefore, based on these studies and the present
results, the elevated temporal beat-to-beat variability in compet-
itive soccer players may indicate a larger repolarization instability
and an increased propensity for ventricular arrhythmias. Notably,
physical deconditioning in trained athletes with no cardiac
structural abnormalities decreased the incidence and complexity
of ventricular tachyarrhytmias [57].
Study limitations
For purely practical and logistic reasons echocardiographic
assessment of all soccer players and all controls were not
performed in this study. However, our echocardiography data
randomly performed on 23 soccer players and 23 controls support
the findings of a number of previous studies showing that
endurance athletes, including soccer players, as part of the
cardiovascular system’s physiological response to long-term intense
physical training, develop athlete’s heart that features myocardial
hypertrophy [12–14,58,59]. In our study, professional soccer
players from the first division were enlisted who participated in
Figure 4. Short-term beat-to-beat temporal variability of the RR (STVRR) and QT (STVQT) intervals in age-matched controls and
professional soccer players before and following a competitive game. Soccer players had a significantly higher STVRR compared to controls
before the game. STVRR was similar to controls in soccer players immediately after the game (A). Poincare´ plots illustrating short-term temporal
variability of the QT interval at rest in a control individual and in a professional soccer player before the game. Note the shift of QT values to the right
and upwards in the soccer player indicating QT prolongation and the increased scattering of QT interval values in the soccer player demonstrating
increased beat-to-beat variability of the QT interval (B). Short-term QT variability was significantly higher in soccer players both before and after the
game compared to controls but also decreased in players compared to pre-game values (C). (n = 76 persons/group; Means 6 S.E.M.; ***p,0.001 vs.
age-matched control; ##p,0.01; ###p,0.001 vs. before game values).
doi:10.1371/journal.pone.0018751.g004
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rigorous endurance training schedule for years based on
international standards. We also found they had significantly
decreased resting heart rate and consequent prolongation of the
QT interval, both are characteristics of athlete’s heart. Based on
the above it is assumed that the echocardiography data are
representative for their respective groups.
Since the duration of repolarization is cycle length dependent,
variability in the RR interval could influence QT variability.
Based on our results, the influence of STVRR on STVQT cannot
be ruled out, however, in professional soccer players STVRR
was reduced and was similar to control values after the
competitive game while STVQT remained significantly higher,
Figure 5. Histograms showing the distribution of the QT interval. (A) Controls (empty bars) and soccer players before game (full bars) and
(B) controls (empty bars) and soccer players after the game (hashed bars). Bin size is 10 ms. (n = 76 persons/group).
doi:10.1371/journal.pone.0018751.g005
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strongly suggesting that STVQT was increased irrespective of
changes in STVRR. The short-term variability of the mono-
phasic action potential was found to be partially influenced by
pacing cycle length and was moderately decreased at faster
cycle lengths in anesthetized dogs with chronic AV block
characterized by marked bradycardia and myocardial hypertro-
phy [52].
We found elevated STVQT in the present study in soccer
players, who were chosen as subjects of the study since the
different degrees of cardiac hypertrophy found in athletes of
Figure 6. Histograms showing the distribution of short-term beat-to-beat variability of the QT interval (STVQT). (A) Controls (empty
bars) and soccer players before game (full bars) and (B) controls (empty bars) and soccer players after the game (hashed bars). Bin size is 0.5 ms.
(n = 76 persons/group).
doi:10.1371/journal.pone.0018751.g006
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different sports [15] may have significant influence on cardiac
repolarization, and sudden cardiac death associated with sports
activity has been reported most commonly in Europe among
soccer players [60]. However, the changes in STVQT can be
different in other sports, depending on type, intensity and duration
of various training schedules used in different sports. Further
studies are needed to confirm whether STVQT elevation is
uniformly present in other endurance athletes.
Conclusions
In conclusion, the short-term variability of the QT interval is
elevated in professional soccer players, which, according to our
present knowledge, might indicate increased repolarization
instability even without any underlying cardiac disease. Based on
the available literature, decreased repolarization reserve due to
downregulation of certain repolarizing potassium currents associ-
ated with myocardial hypertrophy may underlie these changes. As
clinical and animal studies illustrate, increased STVQT may be
more predictive for the development of serious ventricular
arrhythmias than conventional ECG parameters, such as the
prolongation of the QTc interval. In our study, some soccer
players exhibited greatly increased STVQT even when compared
to other players, suggesting that it may be beneficial to screen
athletes for elevated repolarization instability by adding the
relatively low cost STVQT determination to routine ECG
examinations. Individual athletes with large STVQT could be
then subjected to more detailed and sophisticated examinations
(e.g. evaluation of possible mutations in potassium channel protein
encoding genes) to carefully evaluate their vulnerability to
ventricular arrhythmias and sudden cardiac death. Importantly,
our results further support the inclusion of ECG in preparticipa-
tion athlete screening expertly worked out by Corrado et al. [61],
with the notion that calculation of STVQT could also be added to
the ECG evaluation in case our findings can be confirmed in a
broader athlete population. It is important to emphasize that no
arrhythmias were observed among soccer players in this study and
further, more comprehensive investigations are needed to establish
whether the higher STVQT relates to higher arrhythmia
propensity in this population. This study also warrants the
investigation of STVQT in top athletes with various training levels
and in a larger number of athletes preferably taking part in
different types of sports activities to enable investigators to make a
direct link between STVQT, arrhythmia susceptibility and sudden
cardiac death in top competitive athletes.
Acknowledgments
The authors sincerely thank all participating professional soccer players,
clubs and their respective managers and volunteers for their contribution to
this study.
Author Contributions
Conceived and designed the experiments: CL MT TW JGP AV PH.
Performed the experiments: CL AO ZsK EB ET AU GP. Analyzed the
data: AO ZK AU EB IB. Contributed reagents/materials/analysis tools:
GP TW PH AV. Wrote the paper: IB AV CL. Drafted and edited the
manuscript: IB CL PH AV JGP.
References
1. Cameroon star Foe dies: Cameroon midfielder Marc-Vivien Foe dies after
collapsing during an international match in France. Available at: http://news.
bbc.co.uk/sport1/hi/football/3024360.stm. Accessed February 1, 2011.
2. Benfica striker dies. Available at: http://news.bbc.co.uk/sport2/hi/football/
europe/3428803.stm. Accessed February 1, 2011.
3. Motherwell captain O’Donnell dies. Available at: http://news.bbc.co.uk/sport2/
hi/football/teams/m/motherwell/7164150.stm. Accessed February 1, 2011.
4. Corrado D, Michieli P, Basso C, Schiavon M, Thiene G (2007) How to screen
athletes for cardiovascular diseases. Cardiol Clin 25: 391–397.
5. Pigozzi F, Rizzo M (2008) Sudden death in competitive athletes. Clin Sports
Med 27: 153–181.
6. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE (1980) Sudden
death in young athletes. Circulation 62: 218–229.
7. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, et al. (1996) Sudden
death in young competitive athletes. Clinical, demographic, and pathological
profiles. JAMA 276: 199–204.
8. Parratt JR, Ve´gh A´ (1997) Delayed protection against ventricular arrhythmias by
cardiac pacing. Heart 78: 423–425.
9. Kavazis AN (2009) Exercise preconditioning of the myocardium. Sports Med 39:
923–935.
10. Vago H, Toth A, Apor A, Maurovich-Horvat P, Toth M, et al. (2010) Images in
cardiovascular medicine. Cardiac contusion in a professional soccer player:
visualization of acute and late pathological changes in the myocardium with
magnetic resonance imaging. Circulation 121: 2456–2461.
11. Madias C, Maron BJ, Weinstock J, Estes NA, 3rd, Link MS (2007) Commotio
cordis - sudden cardiac death with chest wall impact. J Cardiovasc Electro-
physiol 18: 115–122.
12. Atchley AE Jr., Douglas PS (2007) Left ventricular hypertrophy in athletes:
morphologic features and clinical correlates. Cardiol Clin 25: 371–382.
13. Paolo FM, Pelliccia A. The ‘‘Athlete’s heart’’: relation to gender and race.
Cardiol Clin 2007;25: 383–89.
14. Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, et al. (2002)
Athlete’s heart: right and left ventricular mass and function in male endurance
athletes and untrained individuals determined by magnetic resonance imaging.
J Am Coll Cardiol 40: 1856–1863.
15. Maron BJ, Pelliccia A (2006) The heart of trained athletes: cardiac remodeling
and the risks of sports, including sudden death. Circulation 114: 1633–1644.
16. Janse MJ (2004) Electrophysiological changes in heart failure and their
relationship to arrhythmogenesis. Cardiovasc Res 61: 208–217.
17. Li GR, Lau CP, Leung TK, Nattel S (2004) Ionic current abnormalities
associated with prolonged action potentials in cardiomyocytes from diseased
human right ventricles. Heart Rhythm 1: 460–468.
18. Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel
remodelling in the heart: heart failure, myocardial infarction, and atrial
fibrillation. Physiol Rev 87: 425–456.
19. Vos MA, de Groot SH, Verduyn SC, van der Zande J, Leunissen HD, et al.
(1998) Enhanced susceptibility for acquired torsade de pointes arrhythmias in
the dog with chronic, complete AV block is related to cardiac hypertrophy and
electrical remodeling. Circulation 98: 1125–1135.
20. Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S (2002) Transmural action
potential and ionic current remodelling in ventricles of failing canine hearts.
Am J Physiol Heart Circ Physiol 283: H1031–H1041.
21. Nuss HB, Kaab S, Kass DA, Tomaselli GF, Marba´n E (1999) Cellular basis of
ventricular arrhythmias and abnormal automaticity in heart failure. Am J Physiol
Heart Circ Physiol 277: H80–H91.
22. Rose J, Armoundas AA, Tian Y, DiSilvestre D, Burysek M, et al. (2005)
Molecular correlates of altered expression of potassium currents in failing rabbit
myocardium. Am J Physiol Heart Circ Physiol 288: H2077–H2087.
23. Volders PG, Sipido KR, Vos MA, Spa¨tjens RL, Leunissen JD, et al. (1999)
Downregulation of delayed rectifier K+ currents in dogs with chronic complete
atrioventricular block and acquired torsades de pointes. Circulation 100:
2455–2461.
24. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, et al. (2004)
QT interval variability and spontaneous ventricular tachycardia or fibrillation in
the multicenter automatic defibrillator implantation trial (MADIT) II patients.
J Am Coll Cardiol 44: 1481–1487.
25. Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, et al. (2004)
Increased short-term variability of repolarization predicts d-sotalol-induced
torsades de pointes in dogs. Circulation 110: 2453–2459.
26. Lengyel Cs, Varro´ A, Ta´bori K, Papp JG, Baczko´ I (2007) Combined
pharmacological block of IKr and IKs increases short-term QT interval variability
and provokes torsades de pointes. Brit J Pharmacol 151: 941–951.
27. Hinterseer M, Beckmann BM, Thomsen MB, Pfeufer A, Dalla Pozza R, et al.
(2009) Relation of increased short-term variability of QT interval to congenital
long-QT syndrome. Am J Cardiol 103: 1244–1248.
28. Hinterseer M, Beckmann BM, Thomsen MB, Pfeufer A, Ulbrich M, et al. (2010)
Usefulness of short-term variability of QT intervals as a predictor for electrical
remodeling and proarrhythmia in patients with nonischemic heart failure.
Am J Cardiol 106: 216–220.
29. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding
quantitation in M-mode echocardiography: results of a survey of echocardio-
graphic measurements. Circulation 58: 1072–1083.
30. Pavlik G, Olexo´ Zs, Frenkl R (1996) Echocardiographic estimates related to
various body size measures in athletes. Acta Physiol Hung 84: 171–181.
QT Interval Variability in Soccer Players
PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18751
31. Bazett H (1920) An analysis of the time relationship of electrocardiograms. Heart
7: 353–370.
32. Fridericia LS (1920) Die Systolendauer im elektrokardiogramm bei normalen
menschen und bei herzkranken. Acta Med Scand 53: 489.
33. Indik JH, Pearson EC, Fried K, Woosley RL (2006) Bazett and QT correction
formulas interfere with measurement of drug-induced changes in QT interval.
Heart Rhythm 3: 1003–1007.
34. Volders PG, Sipido KR, Vos MA, Spa¨tjens RL, Leunissen JD, et al. (1999)
Downregulation of delayed rectifier K+ currents in dogs with chronic complete
atrioventricular block and acquired torsades de pointes. Circulation 100:
2455–2461.
35. Varro´ A, Bala´ti B, Iost N, Taka´cs J, Vira´g L, et al. (2000) The role of the delayed
rectifier component IKs in dog ventricular muscle and Purkinje fibre
repolarization. J Physiol 523: 67–81.
36. Jost N, Papp JG, Varro´ A (2007) Slow delayed rectifier potassium current (IKs)
and the repolarization reserve. Ann Noninvasive Electrocardiol 12: 64–78.
37. Roden DM (1998) Taking the idio out of idiosyncratic – predicting torsades de
pointes. Pacing Clin Electrophysiol 21: 1029–1034.
38. Roden DM, Yang T (2005) Protecting the heart against arrhythmias: potassium
current physiology and repolarization reserve. Circulation 112: 1376–1378.
39. Varro´ A, Papp JG (2006) Low penetrance, subclinical congenital LQTS:
concealed LQTS or silent LQTS? Cardiovasc Res 70: 404–406.
40. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, et al.
(1994) Sudden cardiac death in heart failure: the role of abnormal
repolarization. Circulation 90: 2534–2539.
41. Akar FG, Rosenbaum DS (2003) Transmural electrophysiological heterogene-
ities underlying arrhythmogenesis in heart failure. Circ Res 93: 638–645.
42. Tamargo J, Caballero R, Go´mez R, Valenzuela C, Delpo´n E (2004)
Pharmacology of cardiac potassium channels. Cardiovasc Res 62: 9–33.
43. Constable PD, Hinchcliff KW, Olson J, Hamlin RL (1994) Athletic heart
syndrome in dogs competing in a long-distance sled race. J Appl Physiol 76:
433–438.
44. Constable PD, Hinchcliff KW, Olson JL, Stepien RL (2000) Effects of
endurance training on standard and signal-averaged electrocardiograms of sled
dogs. Am J Vet Res 61: 582–588.
45. Hart G (2003) Exercise-induced cardiac hypertrophy: a substrate for sudden
death in athletes? Exp Physiol 88: 639–644.
46. Varro´ A, Baczko´ I (2010) Possible mechanisms of sudden cardiac death in top
athletes: a basic cardiac electrophysiological point of view. Pflu¨g Arch
Eur J Physiol 460: 31–40.
47. Zitron E, Scholz E, Owen RW, Lu¨ck S, Kiesecker C, et al. (2005) QTc
prolongation by grapefruit juice and its potential pharmacological basis. HERG
channel blockade by flavonoids. Circulation 111: 835–838.
48. Frolov RV, Berim IG, Singh S (2008) Inhibition of delayed rectifier potassium
channels and induction of arrhythmia: a novel effect of celecoxib and the
mechanism underlying it. J Biol Chem 283: 1518–1524.
49. DiFrancesco D, Borer JS (2007) The funny current: cellular basis for the control
of heart rate. Drugs 67(Suppl 2): 15–24.
50. Sperelakis N, Katsube Y, Yokoshiki H, Sada H, Sumii K (1996) Regulation of
the slow Ca++ channels of myocardial cells. Mol Cell Biochem 163–64: 85–98.
51. Hinterseer M, Thomsen MB, Beckmann BM, Pfeufer A, Schimpf R, et al. (2008)
Beat-to-beat variability of QT intervals is increased in patients with drug-
induced long-QT syndrome: a case control pilot study. Eur Heart J 29: 185–190.
52. Thomsen MB, Truin M, van Opstal JM, Beekman JD, Volders PG, et al. (2005)
Sudden cardiac death in dogs with remodeled hearts is associated with larger
beat-to-beat variability of repolarization. Basic Res Cardiol 100: 279–287.
53. Thomsen MB, Oros A, Schoenmakers M, van Opstal JM, Maas JN, et al. (2007)
Proarrhythmic electrical remodelling is associated with increased beat-to-beat
variability of repolarisation. Cardiovasc Res 73: 521–530.
54. Hanton G, Yvon A, Racaud A (2008) Temporal variability of QT interval and
changes in T wave morphology in dogs as markers of the clinical risk of drug-
induced proarrhythmia. J Pharmacol Toxicol Methods 57: 194–201.
55. So PP, Backx PH, Dorian P (2008) Slow delayed rectifier K+ current block by
HMR 1556 increases dispersion of repolarization and promotes Torsades de
Pointes in rabbit ventricles. Brit J Pharmacol 155: 1185–1194.
56. Abi-Gerges N, Valentin JP, Pollard CE (2010) Dog left ventricular midmyo-
cardial myocytes for assessment of drug-induced delayed repolarization: short-
term variability and proarrhythmic potential. Brit J Pharmacol 159: 77–92.
57. Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, et al. (2004) Impact of
physical deconditioning on ventricular tachyarrhythmias in trained athletes.
J Am Coll Cardiol 44: 1053–1058.
58. Shapiro LM (1984) Physiological left ventricular hypertrophy. Brit Heart J 52:
130–135.
59. Abernethy WB, Choo JK, Hutter AM (2003) Echocardiographic characteristics
of professional football players. J Am Coll Cardiol 41: 280–284.
60. Corrado D, Basso C, Schiavon M, Thiene G (1998) Screening for hypertrophic
cardiomyopathy in young athletes. N Eng J Med 339: 364–369.
61. Corrado D, Basso C, Schiavon M, Pelliccia A, Thiene G (2008) Pre-
participation screening of young competitive athletes for prevention of sudden
cardiac death. J Am Coll Cardiol 52: 1981–1989.
QT Interval Variability in Soccer Players
PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18751











































